Home Contact Sitemap

eRAM

encyclopedia of Rare Disease Annotation for Precision Medicine



   pick disease
  

Disease ID 187
Disease pick disease
Definition
A rare form of DEMENTIA that is sometimes familial. Clinical features include APHASIA; APRAXIA; CONFUSION; ANOMIA; memory loss; and personality deterioration. This pattern is consistent with the pathologic findings of circumscribed atrophy of the poles of the FRONTAL LOBE and TEMPORAL LOBE. Neuronal loss is maximal in the HIPPOCAMPUS, entorhinal cortex, and AMYGDALA. Some ballooned cortical neurons contain argentophylic (Pick) bodies. (From Brain Pathol 1998 Apr;8(2):339-54; Adams et al., Principles of Neurology, 6th ed, pp1057-9)
Synonym
atrophies, lobar (brain)
atrophy, lobar (brain)
brain atrophy, circumscribed lobar
circumscribed cerebral atrophy
circumscribed lobar atrophy of the brain
dementia frontotemporal
dementia with lobar atrophy and neuronal cytoplasmic inclusions
disease picks
disease, pick
disease, pick's
frontotemporal dementia
lobar atrophies (brain)
lobar atrophy (brain)
lobar atrophy of brain
lobar atrophy of the brain
pick dis
pick dis of the brain
pick disease of brain
pick disease of the brain
pick disease of the brain [disease/finding]
pick s disease
pick's disease
pick's disease (disorder)
picks dis
picks dis of brain
picks disease
picks disease of brain
Orphanet
OMIM
DOID
ICD10
UMLS
C0236642
MeSH
SNOMED-CT
Comorbidity
UMLS | Disease | Sentences' Count(Total Sentences:48)
C0026848  |  myopathy  |  27
C0002736  |  amyotrophic lateral sclerosis  |  16
C0029401  |  paget's disease  |  9
C0029401  |  paget's disease of bone  |  8
C0497327  |  dementia  |  7
C0002395  |  alzheimer's disease  |  5
C0085084  |  motor neuron disease  |  5
C0029401  |  paget disease  |  5
C0029401  |  paget disease of bone  |  5
C0030567  |  parkinson's disease  |  3
C0038868  |  progressive supranuclear palsy  |  3
C0002395  |  alzheimer disease  |  3
C0027121  |  myositis  |  2
C0949664  |  tauopathies  |  2
C0003537  |  aphasia  |  2
C0033975  |  psychosis  |  2
C0679466  |  cognitive deficits  |  2
C0039373  |  tay-sachs disease  |  1
C0042847  |  vitamin b12 defic  |  1
C0085078  |  lysosomal storage disorders  |  1
C0686353  |  limb girdle muscular dystrophy  |  1
C0011269  |  vascular dementia  |  1
C0085084  |  motor neurone disease  |  1
C0030662  |  pathological gambling  |  1
C0024623  |  gastric cancer  |  1
C0027122  |  myositis ossificans  |  1
C0033117  |  priapism  |  1
C0021122  |  impulse control disorders  |  1
C0020255  |  hydrocephalus  |  1
C0003635  |  apraxia  |  1
C0001418  |  adenocarcinoma  |  1
C0005586  |  bipolar affective disorder  |  1
C0028064  |  sphingomyelinase deficiency  |  1
C0027765  |  neurological disorder  |  1
C0036341  |  schizophrenia  |  1
C0030567  |  parkinson disease  |  1
C0017205  |  gaucher disease  |  1
C0751772  |  rem sleep behavior disorder  |  1
C0013421  |  dystonia  |  1
C0037317  |  sleep disturbance  |  1
C0026850  |  muscular dystrophy  |  1
C0020258  |  normal pressure hydrocephalus  |  1
C0005586  |  bipolar disorder  |  1
C0238190  |  inclusion body myositis  |  1
C0021053  |  immune dysfunction  |  1
C0152013  |  lung adenocarcinoma  |  1
C0042847  |  vitamin b12 deficiency  |  1
C0085078  |  lysosomal storage disease  |  1
Curated Gene
Entrez_id | Symbol | Resource(Total Genes:6)
5663  |  PSEN1  |  CLINVAR;CTD_human;UNIPROT
25978  |  CHMP2B  |  CTD_human;UNIPROT
2896  |  GRN  |  CLINVAR;CTD_human;GHR;UNIPROT
4137  |  MAPT  |  CLINVAR;CTD_human;UNIPROT
23435  |  TARDBP  |  UNIPROT
23682  |  RAB38  |  GWASCAT
Inferring Gene
Entrez_id | Symbol | Resource(Total Genes:5)
348  |  APOE  |  CIPHER
2896  |  GRN  |  CIPHER;CTD_human
4137  |  MAPT  |  CIPHER;CTD_human
5663  |  PSEN1  |  CIPHER;CTD_human
25978  |  CHMP2B  |  CTD_human
Text Mined Gene
Entrez_id | Symbol | Score | Resource(Total Genes:240)
9625  |  AATK  |  1.248  |  DISEASES
3983  |  ABLIM1  |  1.402  |  DISEASES
105  |  ADARB2  |  1.981  |  DISEASES
23394  |  ADNP  |  1.895  |  DISEASES
3267  |  AGFG1  |  1.353  |  DISEASES
375790  |  AGRN  |  1.249  |  DISEASES
23287  |  AGTPBP1  |  1.516  |  DISEASES
10189  |  ALYREF  |  2.009  |  DISEASES
9474  |  ATG5  |  1.066  |  DISEASES
10533  |  ATG7  |  1.313  |  DISEASES
23400  |  ATP13A2  |  1.007  |  DISEASES
6311  |  ATXN2  |  3.964  |  DISEASES
4287  |  ATXN3  |  2.181  |  DISEASES
6315  |  ATXN8OS  |  1.304  |  DISEASES
100379571  |  BACE1-AS  |  1.565  |  DISEASES
627  |  BDNF  |  1.373  |  DISEASES
497258  |  BDNF-AS  |  1.501  |  DISEASES
203228  |  C9orf72  |  7.787  |  DISEASES
203228  |  C9orf72  |  2.177  |  DISEASES
815  |  CAMK2A  |  1.658  |  DISEASES
817  |  CAMK2D  |  1.116  |  DISEASES
875  |  CBS  |  4.876  |  DISEASES
875  |  CBS  |  2.907  |  DISEASES
899  |  CCNF  |  2.557  |  DISEASES
960  |  CD44  |  1.444  |  DISEASES
966  |  CD59  |  1.694  |  DISEASES
1020  |  CDK5  |  2.762  |  DISEASES
1020  |  CDK5  |  1.244  |  DISEASES
94027  |  CGB7  |  1.324  |  DISEASES
94115  |  CGB8  |  1.227  |  DISEASES
1103  |  CHAT  |  1.862  |  DISEASES
400916  |  CHCHD10  |  4.938  |  DISEASES
1114  |  CHGB  |  1.417  |  DISEASES
1114  |  CHGB  |  1.317  |  DISEASES
5119  |  CHMP1A  |  2.514  |  DISEASES
1139  |  CHRNA7  |  2.267  |  DISEASES
1267  |  CNP  |  1.447  |  DISEASES
26047  |  CNTNAP2  |  1.148  |  DISEASES
1382  |  CRABP2  |  1.053  |  DISEASES
1453  |  CSNK1D  |  1.604  |  DISEASES
1471  |  CST3  |  1.291  |  DISEASES
51473  |  DCDC2  |  1.603  |  DISEASES
1639  |  DCTN1  |  3.546  |  DISEASES
8525  |  DGKZ  |  2.295  |  DISEASES
3300  |  DNAJB2  |  1.19  |  DISEASES
25911  |  DPCD  |  1.763  |  DISEASES
57628  |  DPP10  |  1.644  |  DISEASES
1804  |  DPP6  |  1.919  |  DISEASES
29102  |  DROSHA  |  1.702  |  DISEASES
79180  |  EFHD2  |  1.514  |  DISEASES
285220  |  EPHA6  |  1.179  |  DISEASES
79956  |  ERMP1  |  2.132  |  DISEASES
2107  |  ETF1  |  1.377  |  DISEASES
2130  |  EWSR1  |  2.9  |  DISEASES
2132  |  EXT2  |  1.912  |  DISEASES
26232  |  FBXO2  |  2.635  |  DISEASES
2205  |  FCER1A  |  1.042  |  DISEASES
2332  |  FMR1  |  1.291  |  DISEASES
100126270  |  FMR1-AS1  |  1.63  |  DISEASES
22862  |  FNDC3A  |  1.514  |  DISEASES
96459  |  FNIP1  |  1.092  |  DISEASES
93986  |  FOXP2  |  1.167  |  DISEASES
2535  |  FZD2  |  1.351  |  DISEASES
2596  |  GAP43  |  1.087  |  DISEASES
2737  |  GLI3  |  4.421  |  DISEASES
10020  |  GNE  |  1.32  |  DISEASES
10013  |  HDAC6  |  2.342  |  DISEASES
3006  |  HIST1H1C  |  2.097  |  DISEASES
3006  |  HIST1H1C  |  1.85  |  DISEASES
3122  |  HLA-DRA  |  1.586  |  DISEASES
3178  |  HNRNPA1  |  4.37  |  DISEASES
3181  |  HNRNPA2B1  |  3.176  |  DISEASES
220988  |  HNRNPA3  |  3.308  |  DISEASES
3187  |  HNRNPH1  |  2.476  |  DISEASES
3188  |  HNRNPH2  |  2.742  |  DISEASES
3190  |  HNRNPK  |  2.186  |  DISEASES
3316  |  HSPB2  |  1.165  |  DISEASES
5654  |  HTRA1  |  1.013  |  DISEASES
3064  |  HTT  |  2.124  |  DISEASES
100750326  |  HTT-AS  |  2.274  |  DISEASES
80173  |  IFT74  |  3.245  |  DISEASES
9118  |  INA  |  3.557  |  DISEASES
9118  |  INA  |  1.763  |  DISEASES
388324  |  INCA1  |  1.577  |  DISEASES
9445  |  ITM2B  |  1.304  |  DISEASES
3725  |  JUN  |  1.059  |  DISEASES
9856  |  KIAA0319  |  1.703  |  DISEASES
547  |  KIF1A  |  1.692  |  DISEASES
347240  |  KIF24  |  2.332  |  DISEASES
11202  |  KLK8  |  1.334  |  DISEASES
3840  |  KPNA4  |  1.022  |  DISEASES
3916  |  LAMP1  |  1.714  |  DISEASES
25802  |  LMOD1  |  1.886  |  DISEASES
25802  |  LMOD1  |  1.528  |  DISEASES
9884  |  LRRC37A  |  1.896  |  DISEASES
374819  |  LRRC37A3  |  1.965  |  DISEASES
259215  |  LY6G6F  |  2.138  |  DISEASES
4128  |  MAOA  |  1.282  |  DISEASES
4129  |  MAOB  |  1.64  |  DISEASES
4133  |  MAP2  |  1.578  |  DISEASES
93487  |  MAPK1IP1L  |  1.241  |  DISEASES
4137  |  MAPT  |  7.508  |  DISEASES
4137  |  MAPT  |  6.381  |  DISEASES
9782  |  MATR3  |  3.2  |  DISEASES
4155  |  MBP  |  1.084  |  DISEASES
4336  |  MOBP  |  2.429  |  DISEASES
4336  |  MOBP  |  2.183  |  DISEASES
219972  |  MPEG1  |  1.724  |  DISEASES
51338  |  MS4A4A  |  1.269  |  DISEASES
4712  |  NDUFB6  |  1.517  |  DISEASES
283131  |  NEAT1  |  1.277  |  DISEASES
4803  |  NGF  |  1.364  |  DISEASES
4828  |  NMB  |  1.368  |  DISEASES
349565  |  NMNAT3  |  1.329  |  DISEASES
147111  |  NOTUM  |  1.439  |  DISEASES
9520  |  NPEPPS  |  1.021  |  DISEASES
55666  |  NPLOC4  |  3.405  |  DISEASES
4897  |  NRCAM  |  1.425  |  DISEASES
4897  |  NRCAM  |  1.157  |  DISEASES
22854  |  NTNG1  |  1.137  |  DISEASES
84628  |  NTNG2  |  1.031  |  DISEASES
51667  |  NUB1  |  2.371  |  DISEASES
51667  |  NUB1  |  1.012  |  DISEASES
55074  |  OXR1  |  1.007  |  DISEASES
5071  |  PARK2  |  2.472  |  DISEASES
11315  |  PARK7  |  1.376  |  DISEASES
11315  |  PARK7  |  1.318  |  DISEASES
22976  |  PAXIP1  |  1.002  |  DISEASES
5094  |  PCBP2  |  1.735  |  DISEASES
54039  |  PCBP3  |  2.261  |  DISEASES
10846  |  PDE10A  |  1.353  |  DISEASES
5252  |  PHF1  |  3.864  |  DISEASES
5252  |  PHF1  |  2.925  |  DISEASES
26227  |  PHGDH  |  2.141  |  DISEASES
8301  |  PICALM  |  1.22  |  DISEASES
65018  |  PINK1  |  2.016  |  DISEASES
23236  |  PLCB1  |  1.426  |  DISEASES
23203  |  PMPCA  |  1.038  |  DISEASES
23509  |  POFUT1  |  2.071  |  DISEASES
9588  |  PRDX6  |  2.258  |  DISEASES
5575  |  PRKAR1B  |  1.091  |  DISEASES
5587  |  PRKD1  |  2.158  |  DISEASES
3276  |  PRMT1  |  1.015  |  DISEASES
10196  |  PRMT3  |  1.26  |  DISEASES
56341  |  PRMT8  |  1.529  |  DISEASES
5621  |  PRNP  |  2.751  |  DISEASES
5621  |  PRNP  |  1.513  |  DISEASES
5660  |  PSAP  |  2.061  |  DISEASES
5663  |  PSEN1  |  6.743  |  DISEASES
5663  |  PSEN1  |  4.904  |  DISEASES
5664  |  PSEN2  |  4.24  |  DISEASES
5718  |  PSMD12  |  1.782  |  DISEASES
5861  |  RAB1A  |  1.147  |  DISEASES
116442  |  RAB39B  |  2.557  |  DISEASES
5886  |  RAD23A  |  1.062  |  DISEASES
5887  |  RAD23B  |  1.145  |  DISEASES
5902  |  RANBP1  |  1.893  |  DISEASES
146713  |  RBFOX3  |  1.809  |  DISEASES
84991  |  RBM17  |  1.489  |  DISEASES
375287  |  RBM43  |  2.231  |  DISEASES
9939  |  RBM8A  |  4.419  |  DISEASES
27316  |  RBMX  |  1.967  |  DISEASES
343035  |  RD3  |  3.62  |  DISEASES
343035  |  RD3  |  1.369  |  DISEASES
10636  |  RGS14  |  1.447  |  DISEASES
55288  |  RHOT1  |  1.132  |  DISEASES
6241  |  RRM2  |  2.446  |  DISEASES
57142  |  RTN4  |  1.746  |  DISEASES
10900  |  RUNDC3A  |  3.198  |  DISEASES
100861563  |  SCAANT1  |  2.283  |  DISEASES
6421  |  SFPQ  |  2.267  |  DISEASES
6421  |  SFPQ  |  2.079  |  DISEASES
51629  |  SLC25A39  |  2.155  |  DISEASES
55676  |  SLC30A6  |  2.516  |  DISEASES
6533  |  SLC6A6  |  1.367  |  DISEASES
140775  |  SMCR8  |  4.573  |  DISEASES
6606  |  SMN1  |  1.232  |  DISEASES
6607  |  SMN2  |  1.312  |  DISEASES
55234  |  SMU1  |  1.527  |  DISEASES
23583  |  SMUG1  |  4.155  |  DISEASES
6622  |  SNCA  |  4.397  |  DISEASES
6622  |  SNCA  |  4.057  |  DISEASES
114815  |  SORCS1  |  1.575  |  DISEASES
57537  |  SORCS2  |  2.172  |  DISEASES
22986  |  SORCS3  |  2.364  |  DISEASES
26206  |  SPAG8  |  2.082  |  DISEASES
8878  |  SQSTM1  |  4.654  |  DISEASES
8878  |  SQSTM1  |  2.03  |  DISEASES
6731  |  SRP72  |  2.26  |  DISEASES
9295  |  SRSF11  |  1.958  |  DISEASES
6427  |  SRSF2  |  1.207  |  DISEASES
6428  |  SRSF3  |  1.482  |  DISEASES
6429  |  SRSF4  |  1.279  |  DISEASES
10948  |  STARD3  |  2.112  |  DISEASES
6780  |  STAU1  |  1.098  |  DISEASES
246744  |  STH  |  2.338  |  DISEASES
246744  |  STH  |  1.929  |  DISEASES
23673  |  STX12  |  1.99  |  DISEASES
6829  |  SUPT5H  |  1.668  |  DISEASES
127833  |  SYT2  |  1.063  |  DISEASES
8148  |  TAF15  |  1.207  |  DISEASES
29110  |  TBK1  |  3.522  |  DISEASES
55775  |  TDP1  |  1.345  |  DISEASES
7072  |  TIA1  |  1.186  |  DISEASES
7073  |  TIAL1  |  2.27  |  DISEASES
113277  |  TMEM106A  |  2.61  |  DISEASES
54664  |  TMEM106B  |  5.84  |  DISEASES
54664  |  TMEM106B  |  1.73  |  DISEASES
8792  |  TNFRSF11A  |  1.788  |  DISEASES
3842  |  TNPO1  |  3.89  |  DISEASES
30000  |  TNPO2  |  1.881  |  DISEASES
11076  |  TPPP  |  1.931  |  DISEASES
11076  |  TPPP  |  1.528  |  DISEASES
6434  |  TRA2B  |  3.247  |  DISEASES
54209  |  TREM2  |  4.489  |  DISEASES
7311  |  UBA52  |  3.14  |  DISEASES
7311  |  UBA52  |  1.31  |  DISEASES
51271  |  UBAP1  |  1.704  |  DISEASES
55833  |  UBAP2  |  2.049  |  DISEASES
7316  |  UBC  |  1.939  |  DISEASES
10477  |  UBE2E3  |  1.586  |  DISEASES
65264  |  UBE2Z  |  1.733  |  DISEASES
29979  |  UBQLN1  |  1.422  |  DISEASES
29978  |  UBQLN2  |  5.346  |  DISEASES
29978  |  UBQLN2  |  2.514  |  DISEASES
101410542  |  UCHL1-AS1  |  2.436  |  DISEASES
8408  |  ULK1  |  2.255  |  DISEASES
9094  |  UNC119  |  1.346  |  DISEASES
23025  |  UNC13A  |  2.799  |  DISEASES
26019  |  UPF2  |  1.858  |  DISEASES
7398  |  USP1  |  1.836  |  DISEASES
64854  |  USP46  |  1.536  |  DISEASES
6843  |  VAMP1  |  2.179  |  DISEASES
9217  |  VAPB  |  2.545  |  DISEASES
7415  |  VCP  |  6.518  |  DISEASES
7415  |  VCP  |  2.003  |  DISEASES
389136  |  VGLL3  |  1.574  |  DISEASES
143187  |  VTI1A  |  1.422  |  DISEASES
653440  |  WASH6P  |  1.921  |  DISEASES
11060  |  WWP2  |  3.048  |  DISEASES
Locus(Waiting for update.)
Disease ID 187
Disease pick disease
Integrated Phenotype(Waiting for update.)
Text Mined Phenotype
HPO | Name | Sentences' Count(Total Phenotypes:44)
HP:0001300  |  Parkinsonism  |  116
HP:0003198  |  Myopathic changes  |  28
HP:0100315  |  Lewy bodies  |  24
HP:0007354  |  Amyotrophic lateral sclerosis  |  17
HP:0000726  |  Dementia  |  8
HP:0000708  |  Behavioral problems  |  6
HP:0100543  |  Cognitive deficits  |  3
HP:0002511  |  Late-onset form of familial Alzheimer disease  |  3
HP:0000741  |  Apathy  |  3
HP:0007302  |  Bipolar disorder  |  2
HP:0000709  |  Psychosis  |  2
HP:0002381  |  Aphasia  |  2
HP:0002524  |  Cataplexy  |  2
HP:0002180  |  Neurodegeneration  |  2
HP:0002120  |  Cerebral cortical atrophy  |  2
HP:0100614  |  Muscle inflammation  |  2
HP:0001662  |  Bradycardia  |  1
HP:0100502  |  Vitamin B12 deficiency  |  1
HP:0002271  |  Autonomic dysregulation  |  1
HP:0030219  |  Semantic dementia  |  1
HP:0002354  |  Memory loss  |  1
HP:0001399  |  Liver failure  |  1
HP:0002185  |  Paired helical filaments  |  1
HP:0001332  |  Dystonia  |  1
HP:0000734  |  Disinhibition  |  1
HP:0000238  |  Nonsyndromal hydrocephalus  |  1
HP:0000757  |  Lack of insight  |  1
HP:0000751  |  Personality changes  |  1
HP:0006785  |  Limb-girdle muscular dystrophy  |  1
HP:0002343  |  Normal-pressure hydrocephalus  |  1
HP:0002529  |  Neuronal loss in central nervous system  |  1
HP:0012126  |  Gastric cancer  |  1
HP:0003077  |  Hyperlipidemia  |  1
HP:0001250  |  Seizures  |  1
HP:0002360  |  Sleep disturbance  |  1
HP:0100753  |  Schizophrenia  |  1
HP:0002015  |  Swallowing difficulty  |  1
HP:0012444  |  Brain wasting  |  1
HP:0011098  |  Verbal dyspraxia  |  1
HP:0002186  |  Apraxia  |  1
HP:0003560  |  Muscular dystrophy  |  1
HP:0001257  |  Spasticity  |  1
HP:0030078  |  Lung adenocarcinoma  |  1
HP:0200023  |  Priapism  |  1
Disease ID 187
Disease pick disease
Manually Symptom
UMLS  | Name(Total Manually Symptoms:1)
C0270707  |  kluver-bucy syndrome
Text Mined Symptom
UMLS | Name | Sentences' Count(Total Symptoms:8)
C0026848  |  myopathy  |  28
C0871189  |  psychotic symptoms  |  3
C0235946  |  cortical atrophy  |  2
C0679466  |  cognitive deficits  |  2
C0235946  |  brain atrophy  |  1
C0085084  |  motor neurone disease  |  1
C0497327  |  dementia  |  1
C0004941  |  behavioral symptoms  |  1
Manually Genotype(Total Text Mining Genotypes:0)
(Waiting for update.)
Text Mining Genotype(Total Genotypes:0)
(Waiting for update.)
All Snps(Total Genotypes:176)
snpId pubmedId geneId geneSymbol diseaseId sourceId sentence score Year geneSymbol_dbSNP CHROMOSOME POS REF ALT
rs121909329195060197415VCPumls:C0236642BeFreeTherefore, we propose that hIBMPFTD p97/VCP mutants p97(R155P) and p97(A232E) possess structural defects that may compromise the mechanism of p97/VCP activity within large multiprotein complexes.0.0179151642009VCP935065363CT,G
rs121909329183416087415VCPumls:C0338451BeFreeInclusion body myopathy, Paget's disease of the bone and frontotemporal dementia: recurrence of the VCP R155H mutation in an Italian family and implications for genetic counselling.0.0190009312008VCP935065363CT,G
rs121909329195060197415VCPumls:C0338451BeFreeTherefore, we propose that hIBMPFTD p97/VCP mutants p97(R155P) and p97(A232E) possess structural defects that may compromise the mechanism of p97/VCP activity within large multiprotein complexes.0.0190009312009VCP935065363CT,G
rs121909329183416087415VCPumls:C0236642BeFreeInclusion body myopathy, Paget's disease of the bone and frontotemporal dementia: recurrence of the VCP R155H mutation in an Italian family and implications for genetic counselling.0.0179151642008VCP935065363CT,G
rs121909330213209827415VCPumls:C0338451BeFreeInclusion body myopathy with Paget disease of bone and frontotemporal dementia linked to VCP p.Arg155Cys in a Korean family.0.0190009312011VCP935065364GA
rs121909330213209827415VCPumls:C0236642BeFreeInclusion body myopathy with Paget disease of bone and frontotemporal dementia linked to VCP p.Arg155Cys in a Korean family.0.0179151642011VCP935065364GA
rs121909331195060197415VCPumls:C0236642BeFreeTherefore, we propose that hIBMPFTD p97/VCP mutants p97(R155P) and p97(A232E) possess structural defects that may compromise the mechanism of p97/VCP activity within large multiprotein complexes.0.0179151642009VCP935064167GT
rs121909331195060197415VCPumls:C0338451BeFreeTherefore, we propose that hIBMPFTD p97/VCP mutants p97(R155P) and p97(A232E) possess structural defects that may compromise the mechanism of p97/VCP activity within large multiprotein complexes.0.0190009312009VCP935064167GT
rs140547520243092685216PFN1umls:C0338451BeFreeHere, we combine a screen of a new cohort of 383 ALS patients with multiple-sequence datasets to refine estimates of the ALS and FTD risk associated with PFN1 E117G.0.0010857672014PFN1174945973TC
rs140547520243092685216PFN1umls:C0236642BeFreeHere, we combine a screen of a new cohort of 383 ALS patients with multiple-sequence datasets to refine estimates of the ALS and FTD risk associated with PFN1 E117G.0.0010857672014PFN1174945973TC
rs143624519235186644137MAPTumls:C0338451BeFreeNeurodegenerative disease phenotypes in carriers of MAPT p.A152T, a risk factor for frontotemporal dementia spectrum disorders and Alzheimer disease.0.4613032882014MAPT1745991484GA,T
rs143624519235186644137MAPTumls:C0236642BeFreeNeurodegenerative disease phenotypes in carriers of MAPT p.A152T, a risk factor for frontotemporal dementia spectrum disorders and Alzheimer disease.0.4316705862014MAPT1745991484GA,T
rs1816121122064137MAPTumls:C0338451BeFreeFurthermore, we analyzed some markers located in the common region of linkage (D17S800-D17S791), associated with some cases of familial frontotemporal dementia (FTDP-17), and the SNPs rs1816 and rs937 close to the tau gene, to determine their possible association with sporadic PSP.0.4613032882002KANSL11746199252AG
rs193026789NA2896GRNumls:C0338451CLINVARNA0.282117097NAGRN1744352047CT
rs19906222509661754664TMEM106Bumls:C0338451BeFreeAssociation of TMEM106B rs1990622 marker and frontotemporal dementia: evidence for a recessive effect and meta-analysis.0.0021715352016NA712244161AG
rs1990622244425782896GRNumls:C0338451BeFreePrevious reports have shown that TMEM106B is a genetic modifier of FTLD-TDP caused by progranulin (GRN) mutations, with the major (risk) allele of rs1990622 associating with earlier age at onset of disease.0.2821170972013NA712244161AG
rs19906222509661754664TMEM106Bumls:C0236642BeFreeAssociation of TMEM106B rs1990622 marker and frontotemporal dementia: evidence for a recessive effect and meta-analysis.0.0010857672016NA712244161AG
rs19906222444257854664TMEM106Bumls:C0338451BeFreePrevious reports have shown that TMEM106B is a genetic modifier of FTLD-TDP caused by progranulin (GRN) mutations, with the major (risk) allele of rs1990622 associating with earlier age at onset of disease.0.0021715352013NA712244161AG
rs199062224442578203228C9orf72umls:C0338451BeFreeIntriguingly, the genotype that confers increased risk for developing FTLD-TDP (major, or T, allele of rs1990622) is associated with later age at onset and death in C9orf72 expansion carriers, providing an example of sign epistasis in human neurodegenerative disease.0.0428878162013NA712244161AG
rs3026682494334423682RAB38umls:C0338451GWASCATWe also identified a potential novel locus at 11q14, encompassing RAB38/CTSC (the transcripts of which are related to lysosomal biology), for the behavioural FTD subtype for which joint analyses showed suggestive association for rs302668 (p=2·44 × 10(-7); 0·814 [0·71-0·92]).0.122014RAB381188143743TC
rs3173615237420802896GRNumls:C0338451BeFreeWe studied the p.T185S TMEM106B genetic variant previously implicated in frontotemporal dementia with TAR DNA binding protein 43 pathology caused by progranulin mutations.0.2821170972013TMEM106B712229791CG
rs31736152374208054664TMEM106Bumls:C0338451BeFreeTMEM106B p.T185S regulates TMEM106B protein levels: implications for frontotemporal dementia.0.0021715352013TMEM106B712229791CG
rs31736152374208054664TMEM106Bumls:C0236642BeFreeTMEM106B p.T185S regulates TMEM106B protein levels: implications for frontotemporal dementia.0.0010857672013TMEM106B712229791CG
rs3173615237420802896GRNumls:C0236642BeFreeWe studied the p.T185S TMEM106B genetic variant previously implicated in frontotemporal dementia with TAR DNA binding protein 43 pathology caused by progranulin mutations.0.0266013032013TMEM106B712229791CG
rs3675430412180345423435TARDBPumls:C0236642BeFreeIn that report, we identified a 53-year-old man carrying a homozygous A382T missense mutation of the TARDBP gene with a complex neurological syndrome including amyotrophic lateral sclerosis, parkinsonian features, motor and vocal tics, and frontotemporal dementia (FTD).0.0187294892011TARDBP111022553GA,C
rs3675430412180345423435TARDBPumls:C0338451BeFreeIn that report, we identified a 53-year-old man carrying a homozygous A382T missense mutation of the TARDBP gene with a complex neurological syndrome including amyotrophic lateral sclerosis, parkinsonian features, motor and vocal tics, and frontotemporal dementia (FTD).0.034744562011TARDBP111022553GA,C
rs370140745238857145663PSEN1umls:C0338451BeFreeThirty brain regions were examined in argyrophilic grain disease (AGD; n = 5), tangle-predominant senile dementia (TPSD; n = 5), Pick disease (n = 4), familial AD (FAD; n = 2; PSEN1 p.G206A and p.S170P), and frontotemporal dementia with parkinsonism linked to chromosome-17 (FTDP-17; n = 2; MAPT p.P301L and IVS10 + 16).0.3690771342013MAPT1745999485GA
rs370140745238857145663PSEN1umls:C0236642BeFreeThirty brain regions were examined in argyrophilic grain disease (AGD; n = 5), tangle-predominant senile dementia (TPSD; n = 5), Pick disease (n = 4), familial AD (FAD; n = 2; PSEN1 p.G206A and p.S170P), and frontotemporal dementia with parkinsonism linked to chromosome-17 (FTDP-17; n = 2; MAPT p.P301L and IVS10 + 16).0.2476103042013MAPT1745999485GA
rs370140745238857144137MAPTumls:C0338451BeFreeThirty brain regions were examined in argyrophilic grain disease (AGD; n = 5), tangle-predominant senile dementia (TPSD; n = 5), Pick disease (n = 4), familial AD (FAD; n = 2; PSEN1 p.G206A and p.S170P), and frontotemporal dementia with parkinsonism linked to chromosome-17 (FTDP-17; n = 2; MAPT p.P301L and IVS10 + 16).0.4613032882013MAPT1745999485GA
rs4878104227853941612DAPK1umls:C0236642BeFreeWe showed a positive association between rs4878104 and FTD, suggesting a possible implication of the DAPK1 genetic variant in the susceptibility to FTD.0.0002714422012DAPK1987578076CT
rs4878104227853941612DAPK1umls:C0338451BeFreeWe showed a positive association between rs4878104 and FTD, suggesting a possible implication of the DAPK1 genetic variant in the susceptibility to FTD.0.0002714422012DAPK1987578076CT
rs584821047645724029MIR659umls:C0236642BeFreeThis is consistent with the finding that miR-659 binding to the high risk T allele of rs5848 may augment translational inhibition of GRN and alter risk of FTD and possibly other dementias.0.0005428842011GRN1744352876CT
rs58481984730523435TARDBPumls:C0338451BeFreeA single nucleotide polymorphism (rs5848) located in the 3'- untranslated region of GRN has recently been associated with a risk of frontotemporal lobar degeneration (FTLD) in North American population particularly in pathologically confirmed cases with neural inclusions immunoreactive for ubiquitin and TAR DNA-binding protein 43 (TDP-43), but negative for tau and alpha-synuclein (FTLD-TDP).0.034744562009GRN1744352876CT
rs5848198473052896GRNumls:C0338451BeFreeA single nucleotide polymorphism (rs5848) located in the 3'- untranslated region of GRN has recently been associated with a risk of frontotemporal lobar degeneration (FTLD) in North American population particularly in pathologically confirmed cases with neural inclusions immunoreactive for ubiquitin and TAR DNA-binding protein 43 (TDP-43), but negative for tau and alpha-synuclein (FTLD-TDP).0.2821170972009GRN1744352876CT
rs584821047645724029MIR659umls:C0338451BeFreeThis is consistent with the finding that miR-659 binding to the high risk T allele of rs5848 may augment translational inhibition of GRN and alter risk of FTD and possibly other dementias.0.0005428842011GRN1744352876CT
rs5848210476452896GRNumls:C0338451BeFreeThis is consistent with the finding that miR-659 binding to the high risk T allele of rs5848 may augment translational inhibition of GRN and alter risk of FTD and possibly other dementias.0.2821170972011GRN1744352876CT
rs5848194733662896GRNumls:C0338451BeFreeA single nucleotide polymorphism in the 3'-untranslated region of the progranulin gene (GRN; 3'UTR+78C>T; rs5848) was reported to alter the risk for frontotemporal lobar degeneration with ubiquitin-positive inclusions (FTLD-U).0.2821170972009GRN1744352876CT
rs5848210476452896GRNumls:C0236642BeFreeThis is consistent with the finding that miR-659 binding to the high risk T allele of rs5848 may augment translational inhibition of GRN and alter risk of FTD and possibly other dementias.0.0266013032011GRN1744352876CT
rs63749817NA2896GRNumls:C0338451CLINVARNA0.282117097NAGRN1744350801GA,C
rs63750082238857145663PSEN1umls:C0236642BeFreeThirty brain regions were examined in argyrophilic grain disease (AGD; n = 5), tangle-predominant senile dementia (TPSD; n = 5), Pick disease (n = 4), familial AD (FAD; n = 2; PSEN1 p.G206A and p.S170P), and frontotemporal dementia with parkinsonism linked to chromosome-17 (FTDP-17; n = 2; MAPT p.P301L and IVS10 + 16).0.2476103042013PSEN11473192712GC,T
rs63750082238857144137MAPTumls:C0338451BeFreeThirty brain regions were examined in argyrophilic grain disease (AGD; n = 5), tangle-predominant senile dementia (TPSD; n = 5), Pick disease (n = 4), familial AD (FAD; n = 2; PSEN1 p.G206A and p.S170P), and frontotemporal dementia with parkinsonism linked to chromosome-17 (FTDP-17; n = 2; MAPT p.P301L and IVS10 + 16).0.4613032882013PSEN11473192712GC,T
rs63750082238857145663PSEN1umls:C0338451BeFreeThirty brain regions were examined in argyrophilic grain disease (AGD; n = 5), tangle-predominant senile dementia (TPSD; n = 5), Pick disease (n = 4), familial AD (FAD; n = 2; PSEN1 p.G206A and p.S170P), and frontotemporal dementia with parkinsonism linked to chromosome-17 (FTDP-17; n = 2; MAPT p.P301L and IVS10 + 16).0.3690771342013PSEN11473192712GC,T
rs63750092NA4137MAPTumls:C0338451CLINVARNA0.461303288NAMAPT1746014277AT
rs63750129NA4137MAPTumls:C0236642CLINVARNA0.431670586NAMAPT1745996612AC
rs63750129184900114137MAPTumls:C0236642BeFreeOur strategy was to use the natural tau promoter for expressing the human-tau (htau) gene with two mutations K257T/P301S (double mutant, DM) associated with severe phenotypes of frontotemporal-dementia in humans.0.4316705862008MAPT1745996612AC
rs63750129184900114137MAPTumls:C0338451BeFreeOur strategy was to use the natural tau promoter for expressing the human-tau (htau) gene with two mutations K257T/P301S (double mutant, DM) associated with severe phenotypes of frontotemporal-dementia in humans.0.4613032882008MAPT1745996612AC
rs63750215161553444137MAPTumls:C0338451BeFreeMoreover, we observed similarly reduced taxol/GTP-stimulated tubulin polymerization from gray matter obtained from patients with AD caused by PSEN2 N141I mutation or frontotemporal dementia with parkinsonism linked to chromosome-17 caused (FTDP-17) by TAU V337M or P301L mutation.0.4613032882005PSEN21226885603AT
rs63750215161553445664PSEN2umls:C0338451BeFreeMoreover, we observed similarly reduced taxol/GTP-stimulated tubulin polymerization from gray matter obtained from patients with AD caused by PSEN2 N141I mutation or frontotemporal dementia with parkinsonism linked to chromosome-17 caused (FTDP-17) by TAU V337M or P301L mutation.0.0037242412005PSEN21226885603AT
rs63750247220722132896GRNumls:C0236642BeFreeThe progranulin gene (GRN) g.10325_10331delCTGCTGT (relative to nt1 in NG_007886.1), alias Cys157LysfsX97, has been so far reported only once in a patient with frontotemporal dementia.0.0266013032012GRN1744350447CTGCTGT-
rs63750247220722132896GRNumls:C0338451BeFreeThe progranulin gene (GRN) g.10325_10331delCTGCTGT (relative to nt1 in NG_007886.1), alias Cys157LysfsX97, has been so far reported only once in a patient with frontotemporal dementia.0.2821170972012GRN1744350447CTGCTGT-
rs63750306234893665663PSEN1umls:C0236642BeFreeThe PS-1 M146V mutation was found in the 50-year-old subject (the proband) with family history of early-onset FTD.0.2476103042013PSEN11473173663AC,G,T
rs63750306234893665663PSEN1umls:C0338451BeFreeThe PS-1 M146V mutation was found in the 50-year-old subject (the proband) with family history of early-onset FTD.0.3690771342013PSEN11473173663AC,G,T
rs63750349170726254137MAPTumls:C0236642BeFreeBiochemical and pathological characterization of frontotemporal dementia due to a Leu266Val mutation in microtubule-associated protein tau in an African American individual.0.4316705862007MAPT1745996638CG,T
rs63750349125098594137MAPTumls:C0338451BeFreeA novel L266V mutation of the tau gene causes frontotemporal dementia with a unique tau pathology.0.4613032882003MAPT1745996638CG,T
rs63750349125098594137MAPTumls:C0236642BeFreeA novel L266V mutation of the tau gene causes frontotemporal dementia with a unique tau pathology.0.4316705862003MAPT1745996638CG,T
rs63750349170726254137MAPTumls:C0338451BeFreeBiochemical and pathological characterization of frontotemporal dementia due to a Leu266Val mutation in microtubule-associated protein tau in an African American individual.0.4613032882007MAPT1745996638CG,T
rs63750349NA4137MAPTumls:C0338451CLINVARNA0.461303288NAMAPT1745996638CG,T
rs63750376109952394137MAPTumls:C0338451BeFreeWe have studied biochemical and structural parameters of several missense and deletion mutants of tau protein (G272V, N279K, DeltaK280, P301L, V337M, R406W) found in frontotemporal dementia and parkinsonism linked to chromosome 17 (FTDP-17).0.4613032882000MAPT1745996657GT
rs63750376NA4137MAPTumls:C0338451CLINVARNA0.461303288NAMAPT1745996657GT
rs63750376109952394137MAPTumls:C0236642BeFreeWe have studied biochemical and structural parameters of several missense and deletion mutants of tau protein (G272V, N279K, DeltaK280, P301L, V337M, R406W) found in frontotemporal dementia and parkinsonism linked to chromosome 17 (FTDP-17).0.4316705862000MAPT1745996657GT
rs63750412172024313483IGFALSumls:C0338451BeFreeA third PGRN sequence variation (R433W) was found in an FTD patient with family history of ALS.0.0048859542007GRN1744352132CT
rs63750412172024313483IGFALSumls:C0236642BeFreeA third PGRN sequence variation (R433W) was found in an FTD patient with family history of ALS.0.0032573022007GRN1744352132CT
rs63750412172024316647SOD1umls:C0236642BeFreeA third PGRN sequence variation (R433W) was found in an FTD patient with family history of ALS.0.0048859542007GRN1744352132CT
rs63750412172024316647SOD1umls:C0338451BeFreeA third PGRN sequence variation (R433W) was found in an FTD patient with family history of ALS.0.0065146052007GRN1744352132CT
rs63750418238857145663PSEN1umls:C0338451BeFreeThirty brain regions were examined in argyrophilic grain disease (AGD; n = 5), tangle-predominant senile dementia (TPSD; n = 5), Pick disease (n = 4), familial AD (FAD; n = 2; PSEN1 p.G206A and p.S170P), and frontotemporal dementia with parkinsonism linked to chromosome-17 (FTDP-17; n = 2; MAPT p.P301L and IVS10 + 16).0.3690771342013PSEN11473186877TC
rs63750418238857145663PSEN1umls:C0236642BeFreeThirty brain regions were examined in argyrophilic grain disease (AGD; n = 5), tangle-predominant senile dementia (TPSD; n = 5), Pick disease (n = 4), familial AD (FAD; n = 2; PSEN1 p.G206A and p.S170P), and frontotemporal dementia with parkinsonism linked to chromosome-17 (FTDP-17; n = 2; MAPT p.P301L and IVS10 + 16).0.2476103042013PSEN11473186877TC
rs63750418238857144137MAPTumls:C0338451BeFreeThirty brain regions were examined in argyrophilic grain disease (AGD; n = 5), tangle-predominant senile dementia (TPSD; n = 5), Pick disease (n = 4), familial AD (FAD; n = 2; PSEN1 p.G206A and p.S170P), and frontotemporal dementia with parkinsonism linked to chromosome-17 (FTDP-17; n = 2; MAPT p.P301L and IVS10 + 16).0.4613032882013PSEN11473186877TC
rs63750424161822624137MAPTumls:C0236642BeFreeMutant R406W human tau was originally identified in frontotemporal dementia and parkinsonism linked to chromosome 17 (FTDP-17) and causes a hereditary tauopathy that clinically resembles Alzheimer's disease (AD).0.4316705862005MAPT1746024061CT
rs63750424123684744137MAPTumls:C0338451BeFreeThe R406W tau mutation found in frontotemporal dementia and parkinsonism linked to chromosome 17 (FTDP-17) causes a hereditary tauopathy clinically resembling Alzheimer's disease.0.4613032882002MAPT1746024061CT
rs63750424109952394137MAPTumls:C0338451BeFreeWe have studied biochemical and structural parameters of several missense and deletion mutants of tau protein (G272V, N279K, DeltaK280, P301L, V337M, R406W) found in frontotemporal dementia and parkinsonism linked to chromosome 17 (FTDP-17).0.4613032882000MAPT1746024061CT
rs63750424123684744137MAPTumls:C0236642BeFreeThe R406W tau mutation found in frontotemporal dementia and parkinsonism linked to chromosome 17 (FTDP-17) causes a hereditary tauopathy clinically resembling Alzheimer's disease.0.4316705862002MAPT1746024061CT
rs63750424124145184137MAPTumls:C0338451BeFreeConditional expression systems for 4-repeat wild-type (WT) tau or the corresponding mutants V337M and R406W were established in human neuroglioma H4 cells to study the effect of tau mutations on the physicochemical properties of tau, and to develop a cellular model for the formation of filamentous tau characteristic of frontotemporal dementia with parkinsonism linked to chromosome 17 (FTDP-17) and Alzheimer's disease.0.4613032882002MAPT1746024061CT
rs63750424NA4137MAPTumls:C0338451CLINVARNA0.461303288NAMAPT1746024061CT
rs63750424109952394137MAPTumls:C0236642BeFreeWe have studied biochemical and structural parameters of several missense and deletion mutants of tau protein (G272V, N279K, DeltaK280, P301L, V337M, R406W) found in frontotemporal dementia and parkinsonism linked to chromosome 17 (FTDP-17).0.4316705862000MAPT1746024061CT
rs63750424253774994137MAPTumls:C0338451BeFreeWe report the autopsy results of a patient with familial dementia who was diagnosed as having frontotemporal dementia with parkinsonism linked to chromosome 17 (FTDP-17) with an R406W mutation in the microtubule-associated protein tau (MAPT) gene.0.4613032882014MAPT1746024061CT
rs63750424161822624137MAPTumls:C0338451BeFreeMutant R406W human tau was originally identified in frontotemporal dementia and parkinsonism linked to chromosome 17 (FTDP-17) and causes a hereditary tauopathy that clinically resembles Alzheimer's disease (AD).0.4613032882005MAPT1746024061CT
rs63750512111931774137MAPTumls:C0236642BeFreeProgress in hereditary tauopathies: a mutation in the Tau gene (G389R) causes a Pick disease-like syndrome.0.4316705862000MAPT1746024010GA,C
rs63750512158446694137MAPTumls:C0236642BeFreeSlow wave and rem sleep mechanisms are differently altered in hereditary pick disease associated with the TAU G389R mutation.0.4316705862005MAPT1746024010GA,C
rs63750512NA4137MAPTumls:C0236642CLINVARNA0.431670586NAMAPT1746024010GA,C
rs63750512158446694137MAPTumls:C0338451BeFreeWe report a longitudinal polysomnographic and 18FDG-PET study in a 38-year-old male with FTDP17 carrying the Tau gene mutation G389R.0.4613032882005MAPT1746024010GA,C
rs63750570NA4137MAPTumls:C0338451CLINVARNA0.461303288NAMAPT1746018629GA
rs63750570254715854137MAPTumls:C0236642BeFreeHere, we address this question using a mouse model expressing the entire human tau gene with an FTD-associated mutation (V337M).0.4316705862015MAPT1746018629GA
rs63750570109952394137MAPTumls:C0236642BeFreeWe have studied biochemical and structural parameters of several missense and deletion mutants of tau protein (G272V, N279K, DeltaK280, P301L, V337M, R406W) found in frontotemporal dementia and parkinsonism linked to chromosome 17 (FTDP-17).0.4316705862000MAPT1746018629GA
rs6375057098113254137MAPTumls:C0338451BeFreeThe conclusion is that the type and distribution of tau deposits in HFTD1 and HFTD2, the physical structure of filaments, and tau isoform composition in HFTD1 differ from Alzheimer's disease and an FTDP-17 family with a V337M mutation in the tau gene.0.4613032881998MAPT1746018629GA
rs63750570161553445664PSEN2umls:C0338451BeFreeMoreover, we observed similarly reduced taxol/GTP-stimulated tubulin polymerization from gray matter obtained from patients with AD caused by PSEN2 N141I mutation or frontotemporal dementia with parkinsonism linked to chromosome-17 caused (FTDP-17) by TAU V337M or P301L mutation.0.0037242412005MAPT1746018629GA
rs63750570109952394137MAPTumls:C0338451BeFreeWe have studied biochemical and structural parameters of several missense and deletion mutants of tau protein (G272V, N279K, DeltaK280, P301L, V337M, R406W) found in frontotemporal dementia and parkinsonism linked to chromosome 17 (FTDP-17).0.4613032882000MAPT1746018629GA
rs63750570124145184137MAPTumls:C0338451BeFreeConditional expression systems for 4-repeat wild-type (WT) tau or the corresponding mutants V337M and R406W were established in human neuroglioma H4 cells to study the effect of tau mutations on the physicochemical properties of tau, and to develop a cellular model for the formation of filamentous tau characteristic of frontotemporal dementia with parkinsonism linked to chromosome 17 (FTDP-17) and Alzheimer's disease.0.4613032882002MAPT1746018629GA
rs63750570254715854137MAPTumls:C0338451BeFreeHere, we address this question using a mouse model expressing the entire human tau gene with an FTD-associated mutation (V337M).0.4613032882015MAPT1746018629GA
rs63750570161553444137MAPTumls:C0338451BeFreeMoreover, we observed similarly reduced taxol/GTP-stimulated tubulin polymerization from gray matter obtained from patients with AD caused by PSEN2 N141I mutation or frontotemporal dementia with parkinsonism linked to chromosome-17 caused (FTDP-17) by TAU V337M or P301L mutation.0.4613032882005MAPT1746018629GA
rs63750573150475904137MAPTumls:C0236642BeFreeFrontotemporal dementia with Pick-type histology associated with Q336R mutation in the tau gene.0.4316705862004MAPT1746018627AG
rs63750573239983004137MAPTumls:C0236642BeFreeWe report a case of frontotemporal dementia caused by a novel MAPT mutation (Q351R) with a remarkably long amnestic presentation mimicking familial Alzheimer's disease.0.4316705862015MAPT1746018627AG
rs63750573150475904137MAPTumls:C0338451BeFreeFrontotemporal dementia with Pick-type histology associated with Q336R mutation in the tau gene.0.4613032882004MAPT1746018627AG
rs63750573239983004137MAPTumls:C0338451BeFreeWe report a case of frontotemporal dementia caused by a novel MAPT mutation (Q351R) with a remarkably long amnestic presentation mimicking familial Alzheimer's disease.0.4613032882015MAPT1746018627AG
rs63750635NA4137MAPTumls:C0236642CLINVARNA0.431670586NAMAPT1746014286CT
rs63750711111175414137MAPTumls:C0236642BeFreeWe report on a 55-year old woman with frontotemporal dementia and a family history of FTDP-17 in whom we found a novel E12 (Glu342Val) tau gene mutation, prominent frontotemporal neuron loss, intracytoplasmic tau aggregates, paired helical tau filaments, increased 4R tau messenger RNA, increased 4R tau without E2 or E3 inserts, decreased 4R tau with these inserts, and a 4R:3R tau ratio greater than 1 in gray and white matter.0.4316705862000MAPT1746018645AT
rs63750711111175414137MAPTumls:C0338451BeFreeWe report on a 55-year old woman with frontotemporal dementia and a family history of FTDP-17 in whom we found a novel E12 (Glu342Val) tau gene mutation, prominent frontotemporal neuron loss, intracytoplasmic tau aggregates, paired helical tau filaments, increased 4R tau messenger RNA, increased 4R tau without E2 or E3 inserts, decreased 4R tau with these inserts, and a 4R:3R tau ratio greater than 1 in gray and white matter.0.4613032882000MAPT1746018645AT
rs63750711NA4137MAPTumls:C0338451CLINVARNA0.461303288NAMAPT1746018645AT
rs63750756173192864137MAPTumls:C0236642BeFreeWe present a case of frontotemporal dementia and parkinsonism linked to chromosome 17 (FTDP-17) harboring the N279K mutation in the MAPT gene from the family known as pallido-ponto-nigral degeneration (PPND).0.4316705862007MAPT1746010324TG
rs63750756176394294137MAPTumls:C0338451BeFreeHere we show that Lrrk2 is closely associated with the tau-positive inclusions in eight members of a family with frontotemporal dementia of the pallido-ponto-nigral degeneration type linked to the chromosome 17 N279K tau mutation (N279K/FTDP-17/PPND).0.4613032882007MAPT1746010324TG
rs63750756176394294137MAPTumls:C0236642BeFreeHere we show that Lrrk2 is closely associated with the tau-positive inclusions in eight members of a family with frontotemporal dementia of the pallido-ponto-nigral degeneration type linked to the chromosome 17 N279K tau mutation (N279K/FTDP-17/PPND).0.4316705862007MAPT1746010324TG
rs63750756171968724137MAPTumls:C0236642BeFreeThe objective of this clinical-pathologic study was to identify biomarkers for a pallidopontonigral degeneration (PPND) kindred of frontotemporal dementia and parkinsonism linked to chromosome 17 (FTDP-17) harboring the N279K tau mutation.0.4316705862007MAPT1746010324TG
rs63750756124921384137MAPTumls:C0338451BeFreePhysiologic assessment of autonomic dysfunction in pallidopontonigral degeneration with N279K mutation in the tau gene on chromosome 17.0.4613032882002MAPT1746010324TG
rs63750756216817974137MAPTumls:C0236642BeFreePallido-ponto-nigral degeneration (PPND), caused by an N279K mutation of the MAPT gene, is 1 of a family of disorders collectively referred to as frontotemporal dementia and parkinsonism linked to chromosome 17.0.4316705862011MAPT1746010324TG
rs63750756124921384137MAPTumls:C0236642BeFreeAutonomic function was investigated in five affected and five at-risk members of a single kinship of pallidopontonigral degeneration (PPND), which is a progressive syndrome of parkinsonism and frontotemporal dementia resulting from a mutation in the N279K tau gene on chromosome 17.0.4316705862002MAPT1746010324TG
rs63750756109952394137MAPTumls:C0338451BeFreeWe have studied biochemical and structural parameters of several missense and deletion mutants of tau protein (G272V, N279K, DeltaK280, P301L, V337M, R406W) found in frontotemporal dementia and parkinsonism linked to chromosome 17 (FTDP-17).0.4613032882000MAPT1746010324TG
rs6375075617639429120892LRRK2umls:C0338451BeFreeHere we show that Lrrk2 is closely associated with the tau-positive inclusions in eight members of a family with frontotemporal dementia of the pallido-ponto-nigral degeneration type linked to the chromosome 17 N279K tau mutation (N279K/FTDP-17/PPND).0.0029099162007MAPT1746010324TG
rs63750756216817974137MAPTumls:C0338451BeFreePallido-ponto-nigral degeneration (PPND), caused by an N279K mutation of the MAPT gene, is 1 of a family of disorders collectively referred to as frontotemporal dementia and parkinsonism linked to chromosome 17.0.4613032882011MAPT1746010324TG
rs63750756120569304137MAPTumls:C0338451BeFreeClinical features and disease haplotypes of individuals with the N279K tau gene mutation: a comparison of the pallidopontonigral degeneration kindred and a French family.0.4613032882002MAPT1746010324TG
rs63750756NA4137MAPTumls:C0338451CLINVARNA0.461303288NAMAPT1746010324TG
rs63750756109952394137MAPTumls:C0236642BeFreeWe have studied biochemical and structural parameters of several missense and deletion mutants of tau protein (G272V, N279K, DeltaK280, P301L, V337M, R406W) found in frontotemporal dementia and parkinsonism linked to chromosome 17 (FTDP-17).0.4316705862000MAPT1746010324TG
rs63750756171968724137MAPTumls:C0338451BeFreeThe objective of this clinical-pathologic study was to identify biomarkers for a pallidopontonigral degeneration (PPND) kindred of frontotemporal dementia and parkinsonism linked to chromosome 17 (FTDP-17) harboring the N279K tau mutation.0.4613032882007MAPT1746010324TG
rs6375075617639429120892LRRK2umls:C0236642BeFreeHere we show that Lrrk2 is closely associated with the tau-positive inclusions in eight members of a family with frontotemporal dementia of the pallido-ponto-nigral degeneration type linked to the chromosome 17 N279K tau mutation (N279K/FTDP-17/PPND).0.0005428842007MAPT1746010324TG
rs63750756173192864137MAPTumls:C0338451BeFreeWe present a case of frontotemporal dementia and parkinsonism linked to chromosome 17 (FTDP-17) harboring the N279K mutation in the MAPT gene from the family known as pallido-ponto-nigral degeneration (PPND).0.4613032882007MAPT1746010324TG
rs63750869213437074137MAPTumls:C0236642BeFreeMAPT V363I variation in a sporadic case of frontotemporal dementia: variable penetrant mutation or rare polymorphism?0.4316705862011MAPT1746018707GA
rs63750869213437074137MAPTumls:C0338451BeFreeMAPT V363I variation in a sporadic case of frontotemporal dementia: variable penetrant mutation or rare polymorphism?0.4613032882011MAPT1746018707GA
rs63750905157652464137MAPTumls:C0236642BeFreeNovel G335V mutation in the tau gene associated with early onset familial frontotemporal dementia.0.4316705862005MAPT1746018624GT
rs63750905157652464137MAPTumls:C0338451BeFreeNovel G335V mutation in the tau gene associated with early onset familial frontotemporal dementia.0.4613032882005MAPT1746018624GT
rs63750912NA4137MAPTumls:C0338451CLINVARNA0.461303288NAMAPT1746010375TC
rs63750959119210594137MAPTumls:C0338451UNIPROTLate-onset frontotemporal dementia with a novel exon 1 (Arg5His) tau gene mutation.0.4613032882002MAPT1745962351GA,T
rs63750959119210594137MAPTumls:C0236642BeFreeLate-onset frontotemporal dementia with a novel exon 1 (Arg5His) tau gene mutation.0.4316705862002MAPT1745962351GA,T
rs63750959NA4137MAPTumls:C0338451CLINVARNA0.461303288NAMAPT1745962351GA,T
rs63750959119210594137MAPTumls:C0338451BeFreeLate-onset frontotemporal dementia with a novel exon 1 (Arg5His) tau gene mutation.0.4613032882002MAPT1745962351GA,T
rs63750972NA4137MAPTumls:C0338451CLINVARNA0.461303288NAMAPT1746010416CT
rs63751068NA5663PSEN1umls:C0236642CLINVARNA0.247610304NAPSEN11473186920GT
rs63751165102085784137MAPTumls:C0236642BeFreeWe report a Japanese family with early onset hereditary frontotemporal dementia and a novel missense mutation (Ser305Asn) in the tau gene.0.4316705861999MAPT1746010401GA
rs63751165NA4137MAPTumls:C0338451CLINVARNA0.461303288NAMAPT1746010401GA
rs63751165102085784137MAPTumls:C0338451BeFreeWe report a Japanese family with early onset hereditary frontotemporal dementia and a novel missense mutation (Ser305Asn) in the tau gene.0.4613032881999MAPT1746010401GA
rs63751264NA4137MAPTumls:C0236642CLINVARNA0.431670586NAMAPT1746018726AT
rs63751273147579344137MAPTumls:C0338451BeFreeNeuropathological and biochemical findings are reported in a patient who had suffered from frontotemporal dementia associated with a P310L mutation in the tau gene and included in the H1 haplotype.0.4613032882003MAPT1746010389CT
rs63751273161553444137MAPTumls:C0338451BeFreeMoreover, we observed similarly reduced taxol/GTP-stimulated tubulin polymerization from gray matter obtained from patients with AD caused by PSEN2 N141I mutation or frontotemporal dementia with parkinsonism linked to chromosome-17 caused (FTDP-17) by TAU V337M or P301L mutation.0.4613032882005MAPT1746010389CT
rs63751273238857145663PSEN1umls:C0338451BeFreeThirty brain regions were examined in argyrophilic grain disease (AGD; n = 5), tangle-predominant senile dementia (TPSD; n = 5), Pick disease (n = 4), familial AD (FAD; n = 2; PSEN1 p.G206A and p.S170P), and frontotemporal dementia with parkinsonism linked to chromosome-17 (FTDP-17; n = 2; MAPT p.P301L and IVS10 + 16).0.3690771342013MAPT1746010389CT
rs63751273121112974137MAPTumls:C0236642BeFreeContrasting genotypes of the tau gene in two phenotypically distinct patients with P301L mutation of frontotemporal dementia and parkinsonism linked to chromosome 17.0.4316705862002MAPT1746010389CT
rs63751273225611284137MAPTumls:C0338451BeFreeThe P301L mutation is causal for frontotemporal dementia with parkinsonism-17 (FTDP-17), but it has been used for studying memory effects characteristic of AD in transgenic mice.0.4613032882012MAPT1746010389CT
rs63751273121112974137MAPTumls:C0338451BeFreeContrasting genotypes of the tau gene in two phenotypically distinct patients with P301L mutation of frontotemporal dementia and parkinsonism linked to chromosome 17.0.4613032882002MAPT1746010389CT
rs63751273238857144137MAPTumls:C0338451BeFreeThirty brain regions were examined in argyrophilic grain disease (AGD; n = 5), tangle-predominant senile dementia (TPSD; n = 5), Pick disease (n = 4), familial AD (FAD; n = 2; PSEN1 p.G206A and p.S170P), and frontotemporal dementia with parkinsonism linked to chromosome-17 (FTDP-17; n = 2; MAPT p.P301L and IVS10 + 16).0.4613032882013MAPT1746010389CT
rs63751273177648514137MAPTumls:C0338451BeFreeWe also examined postural sway in mice expressing mutations that mimic frontotemporal dementia with Parkinsonism linked to chromosome 17 (FTDP-17) (T-279, P301L or P301L-nitric oxide synthase 2 (NOS2)(-/-) mice) and that demonstrate motor symptoms.0.4613032882007MAPT1746010389CT
rs63751273102197854137MAPTumls:C0236642BeFreeWe investigated three separate families (designated D, F and G) with frontotemporal dementia that have the same molecular mutation in exon 10 of the tau gene (P301L).0.4316705861999MAPT1746010389CT
rs63751273102197854137MAPTumls:C0338451BeFreeWe investigated three separate families (designated D, F and G) with frontotemporal dementia that have the same molecular mutation in exon 10 of the tau gene (P301L).0.4613032881999MAPT1746010389CT
rs63751273161553445664PSEN2umls:C0338451BeFreeMoreover, we observed similarly reduced taxol/GTP-stimulated tubulin polymerization from gray matter obtained from patients with AD caused by PSEN2 N141I mutation or frontotemporal dementia with parkinsonism linked to chromosome-17 caused (FTDP-17) by TAU V337M or P301L mutation.0.0037242412005MAPT1746010389CT
rs63751273NA4137MAPTumls:C0338451CLINVARNA0.461303288NAMAPT1746010389CT
rs63751273238857145663PSEN1umls:C0236642BeFreeThirty brain regions were examined in argyrophilic grain disease (AGD; n = 5), tangle-predominant senile dementia (TPSD; n = 5), Pick disease (n = 4), familial AD (FAD; n = 2; PSEN1 p.G206A and p.S170P), and frontotemporal dementia with parkinsonism linked to chromosome-17 (FTDP-17; n = 2; MAPT p.P301L and IVS10 + 16).0.2476103042013MAPT1746010389CT
rs63751273177648514843NOS2umls:C0338451BeFreeWe also examined postural sway in mice expressing mutations that mimic frontotemporal dementia with Parkinsonism linked to chromosome 17 (FTDP-17) (T-279, P301L or P301L-nitric oxide synthase 2 (NOS2)(-/-) mice) and that demonstrate motor symptoms.0.0002714422007MAPT1746010389CT
rs63751273147579344137MAPTumls:C0236642BeFreeNeuropathological and biochemical findings are reported in a patient who had suffered from frontotemporal dementia associated with a P310L mutation in the tau gene and included in the H1 haplotype.0.4316705862003MAPT1746010389CT
rs6375127317764851339345NANOS2umls:C0338451BeFreeWe also examined postural sway in mice expressing mutations that mimic frontotemporal dementia with Parkinsonism linked to chromosome 17 (FTDP-17) (T-279, P301L or P301L-nitric oxide synthase 2 (NOS2)(-/-) mice) and that demonstrate motor symptoms.0.0002714422007MAPT1746010389CT
rs63751273158315014137MAPTumls:C0338451BeFreeSignificantly, the reduction in mitochondrial complex V levels in the P301L tau mice revealed using proteomics was also confirmed as decreased in human P301L FTDP-17 (frontotemporal dementia with parkinsonism linked to chromosome 17) brains.0.4613032882005MAPT1746010389CT
rs63751273109952394137MAPTumls:C0236642BeFreeWe have studied biochemical and structural parameters of several missense and deletion mutants of tau protein (G272V, N279K, DeltaK280, P301L, V337M, R406W) found in frontotemporal dementia and parkinsonism linked to chromosome 17 (FTDP-17).0.4316705862000MAPT1746010389CT
rs63751273109952394137MAPTumls:C0338451BeFreeWe have studied biochemical and structural parameters of several missense and deletion mutants of tau protein (G272V, N279K, DeltaK280, P301L, V337M, R406W) found in frontotemporal dementia and parkinsonism linked to chromosome 17 (FTDP-17).0.4613032882000MAPT1746010389CT
rs63751399NA5663PSEN1umls:C0338451CLINVARNA0.369077134NAPSEN11473171047TC
rs63751399151227015663PSEN1umls:C0236642BeFreeInterestingly, two presenilin 1 (PS1) mutations (Leu113Pro and insArg352) recently have been associated with familial FTD albeit without neuropathological confirmation.0.2476103042004PSEN11473171047TC
rs63751399151227015663PSEN1umls:C0338451BeFreeInterestingly, two presenilin 1 (PS1) mutations (Leu113Pro and insArg352) recently have been associated with familial FTD albeit without neuropathological confirmation.0.3690771342004PSEN11473171047TC
rs63751438NA4137MAPTumls:C0338451CLINVARNA0.461303288NAMAPT1746010388CT
rs63751438212126324137MAPTumls:C0338451BeFreeRecent findings, showing the presence of an inflammatory process in the brain of transgenic mice expressing P301S mutated human tau protein, indicate that neuroinflammation may contribute to tau-related degeneration in frontotemporal dementia and parkinsonism linked to chromosome 17 with tau mutations (FTDP-17T).0.4613032882011MAPT1746010388CT
rs63751438184900114137MAPTumls:C0236642BeFreeOur strategy was to use the natural tau promoter for expressing the human-tau (htau) gene with two mutations K257T/P301S (double mutant, DM) associated with severe phenotypes of frontotemporal-dementia in humans.0.4316705862008MAPT1746010388CT
rs63751438212126324137MAPTumls:C0236642BeFreeRecent findings, showing the presence of an inflammatory process in the brain of transgenic mice expressing P301S mutated human tau protein, indicate that neuroinflammation may contribute to tau-related degeneration in frontotemporal dementia and parkinsonism linked to chromosome 17 with tau mutations (FTDP-17T).0.4316705862011MAPT1746010388CT
rs63751438184900114137MAPTumls:C0338451BeFreeOur strategy was to use the natural tau promoter for expressing the human-tau (htau) gene with two mutations K257T/P301S (double mutant, DM) associated with severe phenotypes of frontotemporal-dementia in humans.0.4613032882008MAPT1746010388CT
rs63751438173183024137MAPTumls:C0338451BeFreeIn 9 patients with frontotemporal dementia and parkinsonism linked to chromosome 17 (FTDP-17) with a P301S tau mutation, the predominant phenotype was frontotemporal dementia in 3 and parkinsonism in 6.0.4613032882007MAPT1746010388CT
rs63751438173183024137MAPTumls:C0236642BeFreeIn 9 patients with frontotemporal dementia and parkinsonism linked to chromosome 17 (FTDP-17) with a P301S tau mutation, the predominant phenotype was frontotemporal dementia in 3 and parkinsonism in 6.0.4316705862007MAPT1746010388CT
rs74315452226708776647SOD1umls:C0338451BeFreeCombined fulminant frontotemporal dementia and amyotrophic lateral sclerosis associated with an I113T SOD1 mutation.0.0065146052012SOD12131667356TC
rs74315452226708776647SOD1umls:C0236642BeFreeCombined fulminant frontotemporal dementia and amyotrophic lateral sclerosis associated with an I113T SOD1 mutation.0.0048859542012SOD12131667356TC
rs759326282380036154209TREM2umls:C0236642BeFreeTREM2 in neurodegeneration: evidence for association of the p.R47H variant with frontotemporal dementia and Parkinson's disease.0.0032573022013TREM2;LOC105375056641161514CA,T
rs759326282404196954209TREM2umls:C0236642BeFreeAssessing the role of the TREM2 p.R47H variant as a risk factor for Alzheimer's disease and frontotemporal dementia.0.0032573022013TREM2;LOC105375056641161514CA,T
rs759326282516004254209TREM2umls:C0236642BeFreeR47H TREM2 variant increases risk of typical early-onset Alzheimer's disease but not of prion or frontotemporal dementia.0.0032573022014TREM2;LOC105375056641161514CA,T
rs759326282380036154209TREM2umls:C0338451BeFreeTREM2 in neurodegeneration: evidence for association of the p.R47H variant with frontotemporal dementia and Parkinson's disease.0.0032573022013TREM2;LOC105375056641161514CA,T
rs759326282516004254209TREM2umls:C0338451BeFreeR47H TREM2 variant increases risk of typical early-onset Alzheimer's disease but not of prion or frontotemporal dementia.0.0032573022014TREM2;LOC105375056641161514CA,T
rs759326282404196954209TREM2umls:C0338451BeFreeAssessing the role of the TREM2 p.R47H variant as a risk factor for Alzheimer's disease and frontotemporal dementia.0.0032573022013TREM2;LOC105375056641161514CA,T
rs794729669NA2896GRNumls:C0338451CLINVARNA0.282117097NAGRN1744350341GC
rs794729670NA2896GRNumls:C0338451CLINVARNA0.282117097NAGRN1744351409TG
rs794729671NA2896GRNumls:C0338451CLINVARNA0.282117097NAGRN1744352081-T
rs794729672NA2896GRNumls:C0338451CLINVARNA0.282117097NAGRN1744349251-C
rs803567182323197123435TARDBPumls:C0338451BeFreeThe TDP-43 p.N267S substitution has been previously implicated in both amyotrophic lateral sclerosis and behavioral variant frontotemporal dementia.0.034744562013TARDBP111022209AG
rs803567182323197123435TARDBPumls:C0236642BeFreeThe TDP-43 p.N267S substitution has been previously implicated in both amyotrophic lateral sclerosis and behavioral variant frontotemporal dementia.0.0187294892013TARDBP111022209AG
rs803567262379857023435TARDBPumls:C0236642BeFreeEndogenous progesterone levels and frontotemporal dementia: modulation of TDP-43 and Tau levels in vitro and treatment of the A315T TARDBP mouse model.0.0187294892014TARDBP111022352GA
rs803567262379857023435TARDBPumls:C0338451BeFreeEndogenous progesterone levels and frontotemporal dementia: modulation of TDP-43 and Tau levels in vitro and treatment of the A315T TARDBP mouse model.0.034744562014TARDBP111022352GA
rs937121122064137MAPTumls:C0338451BeFreeFurthermore, we analyzed some markers located in the common region of linkage (D17S800-D17S791), associated with some cases of familial frontotemporal dementia (FTDP-17), and the SNPs rs1816 and rs937 close to the tau gene, to determine their possible association with sporadic PSP.0.4613032882002NANANANANA
rs9897526213437072896GRNumls:C0236642BeFreeThe V363I variation was associated with frontotemporal dementia only in the proband which was also homozygous for the A allele of the progranulin single-nucleotide polymorphism rs9897526 and for methionine at codon 129 of the prion protein gene.0.0266013032011GRN1744349572GA
rs9897526213437072896GRNumls:C0338451BeFreeThe V363I variation was associated with frontotemporal dementia only in the proband which was also homozygous for the A allele of the progranulin single-nucleotide polymorphism rs9897526 and for methionine at codon 129 of the prion protein gene.0.2821170972011GRN1744349572GA
GWASdb Annotation(Total Genotypes:0)
(Waiting for update.)
GWASdb Snp Trait(Total Genotypes:77)
CHR POS SNPID REF ALT ORI_SNPID PMID P_VALUE P_VALUE_TEXT OR/BETA CI95_TEXT GWAS_INITIAL_SAMPLE_SIZE SUB_POPULATION SUPER_POPULATION GWAS_TRAIT HPO_ID HPO_TERM DO_ID DO_TERM MESH_ID MESH_TERM EFO_ID EFO_TERM DOLITE_TERM RISK_ALLELE PUBLICATION_TYPE AA GENE_SYMBOL TYPE REFGENE
13591448rs12027041GCrs12027041210877633.50E-09NANANA533 non-Hispanic white controlsnon-Hispanic white(533)ALL(533)OTHER(533)ALL(533)Progranulin levelsHPOID:0011018Abnormality of the cell cycleDOID:9255frontotemporal dementiaNANAEFOID:0004625progranulin measurementBrain diseaseAlzheimer's diseaseNAResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov't
165732242rs2477786CTrs2477786210877632.10E-24NANANA533 non-Hispanic white controlsnon-Hispanic white(533)ALL(533)OTHER(533)ALL(533)Progranulin levelsHPOID:0011018Abnormality of the cell cycleDOID:9255frontotemporal dementiaNANAEFOID:0004625progranulin measurementBrain diseaseAlzheimer's diseaseNAResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov't
1109818530rs646776CTrs646776210877632.00E-30NA0.18[0.16-0.20] ng/ml decrease533 non-Hispanic white controlsnon-Hispanic white(533)ALL(533)OTHER(533)ALL(533)Progranulin levelsHPOID:0011018Abnormality of the cell cycleDOID:9255frontotemporal dementiaNANAEFOID:0004625progranulin measurementBrain diseaseAlzheimer's diseasers646776-GResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov't
1151372138rs7172GArs7172210877633.90E-22NANANA533 non-Hispanic white controlsnon-Hispanic white(533)ALL(533)OTHER(533)ALL(533)Progranulin levelsHPOID:0011018Abnormality of the cell cycleDOID:9255frontotemporal dementiaNANAEFOID:0004625progranulin measurementBrain diseaseAlzheimer's diseaseNAResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov't
1224518354rs4653579TCrs4653579210877635.30E-26NANANA533 non-Hispanic white controlsnon-Hispanic white(533)ALL(533)OTHER(533)ALL(533)Progranulin levelsHPOID:0011018Abnormality of the cell cycleDOID:9255frontotemporal dementiaNANAEFOID:0004625progranulin measurementBrain diseaseAlzheimer's diseaseNAResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov't
2127860830rs754107CGrs754107210877631.60E-09NANANA533 non-Hispanic white controlsnon-Hispanic white(533)ALL(533)OTHER(533)ALL(533)Progranulin levelsHPOID:0011018Abnormality of the cell cycleDOID:9255frontotemporal dementiaNANAEFOID:0004625progranulin measurementBrain diseaseAlzheimer's diseaseNAResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov't
313400275rs17038082GArs17038082210877632.30E-15NANANA533 non-Hispanic white controlsnon-Hispanic white(533)ALL(533)OTHER(533)ALL(533)Progranulin levelsHPOID:0011018Abnormality of the cell cycleDOID:9255frontotemporal dementiaNANAEFOID:0004625progranulin measurementBrain diseaseAlzheimer's diseaseNAResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov't
350224225rs12632110AGrs12632110210877631.10E-09NANANA533 non-Hispanic white controlsnon-Hispanic white(533)ALL(533)OTHER(533)ALL(533)Progranulin levelsHPOID:0011018Abnormality of the cell cycleDOID:9255frontotemporal dementiaNANAEFOID:0004625progranulin measurementBrain diseaseAlzheimer's diseaseNAResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov't
3125822003rs2003334CTrs2003334210877634.80E-16NANANA533 non-Hispanic white controlsnon-Hispanic white(533)ALL(533)OTHER(533)ALL(533)Progranulin levelsHPOID:0011018Abnormality of the cell cycleDOID:9255frontotemporal dementiaNANAEFOID:0004625progranulin measurementBrain diseaseAlzheimer's diseaseNAResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov't
3169782204rs6804193TCrs6804193210877638.20E-09NANANA533 non-Hispanic white controlsnon-Hispanic white(533)ALL(533)OTHER(533)ALL(533)Progranulin levelsHPOID:0011018Abnormality of the cell cycleDOID:9255frontotemporal dementiaNANAEFOID:0004625progranulin measurementBrain diseaseAlzheimer's diseaseNAResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov't
43318413rs2236052AGrs2236052210877634.50E-08NANANA533 non-Hispanic white controlsnon-Hispanic white(533)ALL(533)OTHER(533)ALL(533)Progranulin levelsHPOID:0011018Abnormality of the cell cycleDOID:9255frontotemporal dementiaNANAEFOID:0004625progranulin measurementBrain diseaseAlzheimer's diseaseNAResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov't
43533066rs1794429CTrs1794429210877633.60E-24NANANA533 non-Hispanic white controlsnon-Hispanic white(533)ALL(533)OTHER(533)ALL(533)Progranulin levelsHPOID:0011018Abnormality of the cell cycleDOID:9255frontotemporal dementiaNANAEFOID:0004625progranulin measurementBrain diseaseAlzheimer's diseaseNAResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov't
47485775rs17828052CTrs17828052210877638.60E-16NANANA533 non-Hispanic white controlsnon-Hispanic white(533)ALL(533)OTHER(533)ALL(533)Progranulin levelsHPOID:0011018Abnormality of the cell cycleDOID:9255frontotemporal dementiaNANAEFOID:0004625progranulin measurementBrain diseaseAlzheimer's diseaseNAResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov't
570927686rs277979CA,G,Trs277979210877634.90E-14NANANA533 non-Hispanic white controlsnon-Hispanic white(533)ALL(533)OTHER(533)ALL(533)Progranulin levelsHPOID:0011018Abnormality of the cell cycleDOID:9255frontotemporal dementiaNANAEFOID:0004625progranulin measurementBrain diseaseAlzheimer's diseaseNAResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov't
5149915676rs2545342CGrs2545342210877632.50E-08NANANA533 non-Hispanic white controlsnon-Hispanic white(533)ALL(533)OTHER(533)ALL(533)Progranulin levelsHPOID:0011018Abnormality of the cell cycleDOID:9255frontotemporal dementiaNANAEFOID:0004625progranulin measurementBrain diseaseAlzheimer's diseaseNAResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov't
5172360034rs2339745GArs2339745210877637.90E-16NANANA533 non-Hispanic white controlsnon-Hispanic white(533)ALL(533)OTHER(533)ALL(533)Progranulin levelsHPOID:0011018Abnormality of the cell cycleDOID:9255frontotemporal dementiaNANAEFOID:0004625progranulin measurementBrain diseaseAlzheimer's diseaseNAResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov't
5175224905rs2434237CArs2434237210877632.50E-17NANANA533 non-Hispanic white controlsnon-Hispanic white(533)ALL(533)OTHER(533)ALL(533)Progranulin levelsHPOID:0011018Abnormality of the cell cycleDOID:9255frontotemporal dementiaNANAEFOID:0004625progranulin measurementBrain diseaseAlzheimer's diseaseNAResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov't
626458265rs6929846TCrs6929846210877631.30E-23NANANA533 non-Hispanic white controlsnon-Hispanic white(533)ALL(533)OTHER(533)ALL(533)Progranulin levelsHPOID:0011018Abnormality of the cell cycleDOID:9255frontotemporal dementiaNANAEFOID:0004625progranulin measurementBrain diseaseAlzheimer's diseaseNAResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov't
632363215rs1980493TCrs1980493249433441.57E-08(All Frontotemporal dementia)1.29[1.16-1.45]1,377 European ancestry behavioural variant cases; 308 European ancestry Semantic dementia cases; 269 European ancestry Progressive nonfluent aphasia cases; 200 European ancestry Frontotremporal dementia with motor neuron disease cases; up to 4,308 European ancestry controlsEuropean(6462)ALL(6462)EUR(6462)ALL(6462)Frontotemporal dementiaHPOID:0000726DementiaDOID:9255frontotemporal dementiaNANANANABrain diseaseAlzheimer's diseasers1980493-TMulticenter StudyResearch Support, N.I.H., Extramural
632429719rs9268856CArs9268856249433445.51E-09(All Frontotemporal dementia)1.24[1.16-1.32]1,377 European ancestry behavioural variant cases; 308 European ancestry Semantic dementia cases; 269 European ancestry Progressive nonfluent aphasia cases; 200 European ancestry Frontotremporal dementia with motor neuron disease cases; up to 4,308 European ancestry controlsEuropean(6462)ALL(6462)EUR(6462)ALL(6462)Frontotemporal dementiaHPOID:0000726DementiaDOID:9255frontotemporal dementiaNANANANABrain diseaseAlzheimer's diseasers9268856-CMulticenter StudyResearch Support, N.I.H., Extramural
632429719rs9268856CArs9268856249433446.00E-09(All Frontotemporal dementia)1.24[1.16-1.32] 1,377 European ancestry behavioural variant cases; 308 European ancestry Semantic dementia cases; 269 European ancestry Progressive nonfluent aphasia cases; 200 European ancestry Frontotremporal dementia with motor neuron disease cases; up to 4,308 European ancestry controlsEuropean(6462)ALL(6462)EUR(6462)ALL(6462)Frontotemporal dementiaHPOID:0000726DementiaDOID:9255frontotemporal dementiaNANANANABrain diseaseAlzheimer's diseasers9268856-CMulticenter StudyResearch Support, N.I.H., Extramural
632431147rs9268877AGrs9268877249433441.05E-08(All Frontotemporal dementia)1.2[1.11-1.30]1,377 European ancestry behavioural variant cases; 308 European ancestry Semantic dementia cases; 269 European ancestry Progressive nonfluent aphasia cases; 200 European ancestry Frontotremporal dementia with motor neuron disease cases; up to 4,308 European ancestry controlsEuropean(6462)ALL(6462)EUR(6462)ALL(6462)Frontotemporal dementiaHPOID:0000726DementiaDOID:9255frontotemporal dementiaNANANANABrain diseaseAlzheimer's diseasers9268877-AMulticenter StudyResearch Support, N.I.H., Extramural
643168117rs9462875AGrs9462875210877631.20E-21NANANA533 non-Hispanic white controlsnon-Hispanic white(533)ALL(533)OTHER(533)ALL(533)Progranulin levelsHPOID:0011018Abnormality of the cell cycleDOID:9255frontotemporal dementiaNANAEFOID:0004625progranulin measurementBrain diseaseAlzheimer's diseaseNAResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov't
76065804rs10263017GCrs10263017210877631.30E-13NANANA533 non-Hispanic white controlsnon-Hispanic white(533)ALL(533)OTHER(533)ALL(533)Progranulin levelsHPOID:0011018Abnormality of the cell cycleDOID:9255frontotemporal dementiaNANAEFOID:0004625progranulin measurementBrain diseaseAlzheimer's diseaseNAResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov't
755542890rs10281500CGrs10281500210877633.20E-21NANANA533 non-Hispanic white controlsnon-Hispanic white(533)ALL(533)OTHER(533)ALL(533)Progranulin levelsHPOID:0011018Abnormality of the cell cycleDOID:9255frontotemporal dementiaNANAEFOID:0004625progranulin measurementBrain diseaseAlzheimer's diseaseNAResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov't
7128580680rs3807306GTrs3807306210877632.00E-14NANANA533 non-Hispanic white controlsnon-Hispanic white(533)ALL(533)OTHER(533)ALL(533)Progranulin levelsHPOID:0011018Abnormality of the cell cycleDOID:9255frontotemporal dementiaNANAEFOID:0004625progranulin measurementBrain diseaseAlzheimer's diseaseNAResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov't
7157438037rs1638021TCrs1638021210877631.10E-13NANANA533 non-Hispanic white controlsnon-Hispanic white(533)ALL(533)OTHER(533)ALL(533)Progranulin levelsHPOID:0011018Abnormality of the cell cycleDOID:9255frontotemporal dementiaNANAEFOID:0004625progranulin measurementBrain diseaseAlzheimer's diseaseNAResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov't
8140812347rs12679196CTrs12679196210877633.10E-16NANANA533 non-Hispanic white controlsnon-Hispanic white(533)ALL(533)OTHER(533)ALL(533)Progranulin levelsHPOID:0011018Abnormality of the cell cycleDOID:9255frontotemporal dementiaNANAEFOID:0004625progranulin measurementBrain diseaseAlzheimer's diseaseNAResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov't
8144599178rs7464822GArs7464822210877631.70E-25NANANA533 non-Hispanic white controlsnon-Hispanic white(533)ALL(533)OTHER(533)ALL(533)Progranulin levelsHPOID:0011018Abnormality of the cell cycleDOID:9255frontotemporal dementiaNANAEFOID:0004625progranulin measurementBrain diseaseAlzheimer's diseaseNAResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov't
996063690rs16936752TGrs16936752210877631.40E-11NANANA533 non-Hispanic white controlsnon-Hispanic white(533)ALL(533)OTHER(533)ALL(533)Progranulin levelsHPOID:0011018Abnormality of the cell cycleDOID:9255frontotemporal dementiaNANAEFOID:0004625progranulin measurementBrain diseaseAlzheimer's diseaseNAResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov't
9128222340rs10986769AGrs10986769210877632.80E-10NANANA533 non-Hispanic white controlsnon-Hispanic white(533)ALL(533)OTHER(533)ALL(533)Progranulin levelsHPOID:0011018Abnormality of the cell cycleDOID:9255frontotemporal dementiaNANAEFOID:0004625progranulin measurementBrain diseaseAlzheimer's diseaseNAResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov't
9139924637rs13301354TCrs13301354210877634.10E-15NANANA533 non-Hispanic white controlsnon-Hispanic white(533)ALL(533)OTHER(533)ALL(533)Progranulin levelsHPOID:0011018Abnormality of the cell cycleDOID:9255frontotemporal dementiaNANAEFOID:0004625progranulin measurementBrain diseaseAlzheimer's diseaseNAResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov't
103183747rs7094698AGrs7094698210877634.90E-09NANANA533 non-Hispanic white controlsnon-Hispanic white(533)ALL(533)OTHER(533)ALL(533)Progranulin levelsHPOID:0011018Abnormality of the cell cycleDOID:9255frontotemporal dementiaNANAEFOID:0004625progranulin measurementBrain diseaseAlzheimer's diseaseNAResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov't
1017244048rs17381591TCrs17381591210877632.90E-20NANANA533 non-Hispanic white controlsnon-Hispanic white(533)ALL(533)OTHER(533)ALL(533)Progranulin levelsHPOID:0011018Abnormality of the cell cycleDOID:9255frontotemporal dementiaNANAEFOID:0004625progranulin measurementBrain diseaseAlzheimer's diseaseNAResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov't
1044869427rs266089AGrs266089210877635.20E-18NANANA533 non-Hispanic white controlsnon-Hispanic white(533)ALL(533)OTHER(533)ALL(533)Progranulin levelsHPOID:0011018Abnormality of the cell cycleDOID:9255frontotemporal dementiaNANAEFOID:0004625progranulin measurementBrain diseaseAlzheimer's diseaseNAResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov't
1071662783rs942576GTrs942576210877638.40E-14NANANA533 non-Hispanic white controlsnon-Hispanic white(533)ALL(533)OTHER(533)ALL(533)Progranulin levelsHPOID:0011018Abnormality of the cell cycleDOID:9255frontotemporal dementiaNANAEFOID:0004625progranulin measurementBrain diseaseAlzheimer's diseaseNAResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov't
10101946445rs1324694CTrs1324694210877632.80E-22NANANA533 non-Hispanic white controlsnon-Hispanic white(533)ALL(533)OTHER(533)ALL(533)Progranulin levelsHPOID:0011018Abnormality of the cell cycleDOID:9255frontotemporal dementiaNANAEFOID:0004625progranulin measurementBrain diseaseAlzheimer's diseaseNAResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov't
1145947464rs10838532GCrs10838532210877632.10E-18NANANA533 non-Hispanic white controlsnon-Hispanic white(533)ALL(533)OTHER(533)ALL(533)Progranulin levelsHPOID:0011018Abnormality of the cell cycleDOID:9255frontotemporal dementiaNANAEFOID:0004625progranulin measurementBrain diseaseAlzheimer's diseaseNAResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov't
1187876911rs302668TCrs302668249433442.00E-07(Behavioural variant FTD)1.23[1.09-1.41] 1,377 European ancestry behavioural variant cases; 308 European ancestry Semantic dementia cases; 269 European ancestry Progressive nonfluent aphasia cases; 200 European ancestry Frontotremporal dementia with motor neuron disease cases; up to 4,308 European ancestry controlsEuropean(6462)ALL(6462)EUR(6462)ALL(6462)Frontotemporal dementiaHPOID:0000726DementiaDOID:9255frontotemporal dementiaNANANANABrain diseaseAlzheimer's diseasers302668-TMulticenter StudyResearch Support, N.I.H., Extramural
1187934068rs16913634GArs16913634249433448.15E-04(Behavioural variant FTD)1.25[1.14-1.37]1,377 European ancestry behavioural variant cases; 308 European ancestry Semantic dementia cases; 269 European ancestry Progressive nonfluent aphasia cases; 200 European ancestry Frontotremporal dementia with motor neuron disease cases; up to 4,308 European ancestry controlsEuropean(6462)ALL(6462)EUR(6462)ALL(6462)Frontotemporal dementiaHPOID:0000726DementiaDOID:9255frontotemporal dementiaNANANANABrain diseaseAlzheimer's diseasers16913634-AMulticenter StudyResearch Support, N.I.H., Extramural
123333578rs2011973CTrs2011973210877631.40E-16NANANA533 non-Hispanic white controlsnon-Hispanic white(533)ALL(533)OTHER(533)ALL(533)Progranulin levelsHPOID:0011018Abnormality of the cell cycleDOID:9255frontotemporal dementiaNANAEFOID:0004625progranulin measurementBrain diseaseAlzheimer's diseaseNAResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov't
1269980141rs484319GCrs484319210877637.40E-21NANANA533 non-Hispanic white controlsnon-Hispanic white(533)ALL(533)OTHER(533)ALL(533)Progranulin levelsHPOID:0011018Abnormality of the cell cycleDOID:9255frontotemporal dementiaNANAEFOID:0004625progranulin measurementBrain diseaseAlzheimer's diseaseNAResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov't
12124854903rs3782257GArs3782257210877639.30E-21NANANA533 non-Hispanic white controlsnon-Hispanic white(533)ALL(533)OTHER(533)ALL(533)Progranulin levelsHPOID:0011018Abnormality of the cell cycleDOID:9255frontotemporal dementiaNANAEFOID:0004625progranulin measurementBrain diseaseAlzheimer's diseaseNAResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov't
1396672110rs541811GCrs541811210877638.40E-08NANANA533 non-Hispanic white controlsnon-Hispanic white(533)ALL(533)OTHER(533)ALL(533)Progranulin levelsHPOID:0011018Abnormality of the cell cycleDOID:9255frontotemporal dementiaNANAEFOID:0004625progranulin measurementBrain diseaseAlzheimer's diseaseNAResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov't
13110960943rs3809346GArs3809346210877631.00E-16NANANA533 non-Hispanic white controlsnon-Hispanic white(533)ALL(533)OTHER(533)ALL(533)Progranulin levelsHPOID:0011018Abnormality of the cell cycleDOID:9255frontotemporal dementiaNANAEFOID:0004625progranulin measurementBrain diseaseAlzheimer's diseaseNAResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov't
1423623827rs1998055GCrs1998055210877639.70E-11NANANA533 non-Hispanic white controlsnon-Hispanic white(533)ALL(533)OTHER(533)ALL(533)Progranulin levelsHPOID:0011018Abnormality of the cell cycleDOID:9255frontotemporal dementiaNANAEFOID:0004625progranulin measurementBrain diseaseAlzheimer's diseaseNAResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov't
1451083594rs4901043TCrs4901043210877638.50E-08NANANA533 non-Hispanic white controlsnon-Hispanic white(533)ALL(533)OTHER(533)ALL(533)Progranulin levelsHPOID:0011018Abnormality of the cell cycleDOID:9255frontotemporal dementiaNANAEFOID:0004625progranulin measurementBrain diseaseAlzheimer's diseaseNAResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov't
1459900020rs2774052AGrs2774052210877634.80E-17NANANA533 non-Hispanic white controlsnon-Hispanic white(533)ALL(533)OTHER(533)ALL(533)Progranulin levelsHPOID:0011018Abnormality of the cell cycleDOID:9255frontotemporal dementiaNANAEFOID:0004625progranulin measurementBrain diseaseAlzheimer's diseaseNAResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov't
1474969167rs2286412CTrs2286412210877636.00E-18NANANA533 non-Hispanic white controlsnon-Hispanic white(533)ALL(533)OTHER(533)ALL(533)Progranulin levelsHPOID:0011018Abnormality of the cell cycleDOID:9255frontotemporal dementiaNANAEFOID:0004625progranulin measurementBrain diseaseAlzheimer's diseaseNAResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov't
1493412743rs2295394GArs2295394210877631.50E-15NANANA533 non-Hispanic white controlsnon-Hispanic white(533)ALL(533)OTHER(533)ALL(533)Progranulin levelsHPOID:0011018Abnormality of the cell cycleDOID:9255frontotemporal dementiaNANAEFOID:0004625progranulin measurementBrain diseaseAlzheimer's diseaseNAResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov't
1540710723rs2075624GArs2075624210877634.60E-17NANANA533 non-Hispanic white controlsnon-Hispanic white(533)ALL(533)OTHER(533)ALL(533)Progranulin levelsHPOID:0011018Abnormality of the cell cycleDOID:9255frontotemporal dementiaNANAEFOID:0004625progranulin measurementBrain diseaseAlzheimer's diseaseNAResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov't
1542160943rs4923918GArs4923918210877633.80E-13NANANA533 non-Hispanic white controlsnon-Hispanic white(533)ALL(533)OTHER(533)ALL(533)Progranulin levelsHPOID:0011018Abnormality of the cell cycleDOID:9255frontotemporal dementiaNANAEFOID:0004625progranulin measurementBrain diseaseAlzheimer's diseaseNAResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov't
1574291023rs3784562GArs3784562210877634.50E-13NANANA533 non-Hispanic white controlsnon-Hispanic white(533)ALL(533)OTHER(533)ALL(533)Progranulin levelsHPOID:0011018Abnormality of the cell cycleDOID:9255frontotemporal dementiaNANAEFOID:0004625progranulin measurementBrain diseaseAlzheimer's diseaseNAResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov't
1578832792rs3813571GTrs3813571210877637.20E-30NANANA533 non-Hispanic white controlsnon-Hispanic white(533)ALL(533)OTHER(533)ALL(533)Progranulin levelsHPOID:0011018Abnormality of the cell cycleDOID:9255frontotemporal dementiaNANAEFOID:0004625progranulin measurementBrain diseaseAlzheimer's diseaseNAResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov't
16630902rs1045274CGrs1045274210877633.00E-26NANANA533 non-Hispanic white controlsnon-Hispanic white(533)ALL(533)OTHER(533)ALL(533)Progranulin levelsHPOID:0011018Abnormality of the cell cycleDOID:9255frontotemporal dementiaNANAEFOID:0004625progranulin measurementBrain diseaseAlzheimer's diseaseNAResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov't
1611097479rs9925481CTrs9925481210877634.10E-14NANANA533 non-Hispanic white controlsnon-Hispanic white(533)ALL(533)OTHER(533)ALL(533)Progranulin levelsHPOID:0011018Abnormality of the cell cycleDOID:9255frontotemporal dementiaNANAEFOID:0004625progranulin measurementBrain diseaseAlzheimer's diseaseNAResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov't
1616094601rs9635480AGrs9635480210877632.90E-12NANANA533 non-Hispanic white controlsnon-Hispanic white(533)ALL(533)OTHER(533)ALL(533)Progranulin levelsHPOID:0011018Abnormality of the cell cycleDOID:9255frontotemporal dementiaNANAEFOID:0004625progranulin measurementBrain diseaseAlzheimer's diseaseNAResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov't
1683989936rs824400CGrs824400210877632.00E-18NANANA533 non-Hispanic white controlsnon-Hispanic white(533)ALL(533)OTHER(533)ALL(533)Progranulin levelsHPOID:0011018Abnormality of the cell cycleDOID:9255frontotemporal dementiaNANAEFOID:0004625progranulin measurementBrain diseaseAlzheimer's diseaseNAResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov't
1685813880rs301164TCrs301164210877631.10E-14NANANA533 non-Hispanic white controlsnon-Hispanic white(533)ALL(533)OTHER(533)ALL(533)Progranulin levelsHPOID:0011018Abnormality of the cell cycleDOID:9255frontotemporal dementiaNANAEFOID:0004625progranulin measurementBrain diseaseAlzheimer's diseaseNAResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov't
1687638855rs2562059CGrs2562059210877634.40E-22NANANA533 non-Hispanic white controlsnon-Hispanic white(533)ALL(533)OTHER(533)ALL(533)Progranulin levelsHPOID:0011018Abnormality of the cell cycleDOID:9255frontotemporal dementiaNANAEFOID:0004625progranulin measurementBrain diseaseAlzheimer's diseaseNAResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov't
1689972345rs2270461TCrs2270461210877632.50E-18NANANA533 non-Hispanic white controlsnon-Hispanic white(533)ALL(533)OTHER(533)ALL(533)Progranulin levelsHPOID:0011018Abnormality of the cell cycleDOID:9255frontotemporal dementiaNANAEFOID:0004625progranulin measurementBrain diseaseAlzheimer's diseaseNAResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov't
1760778932rs2251393GArs2251393210877631.20E-14NANANA533 non-Hispanic white controlsnon-Hispanic white(533)ALL(533)OTHER(533)ALL(533)Progranulin levelsHPOID:0011018Abnormality of the cell cycleDOID:9255frontotemporal dementiaNANAEFOID:0004625progranulin measurementBrain diseaseAlzheimer's diseaseNAResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov't
1775350872rs367539CTrs367539210877635.70E-08NANANA533 non-Hispanic white controlsnon-Hispanic white(533)ALL(533)OTHER(533)ALL(533)Progranulin levelsHPOID:0011018Abnormality of the cell cycleDOID:9255frontotemporal dementiaNANAEFOID:0004625progranulin measurementBrain diseaseAlzheimer's diseaseNAResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov't
1821425936rs12373237GArs12373237210877634.30E-12NANANA533 non-Hispanic white controlsnon-Hispanic white(533)ALL(533)OTHER(533)ALL(533)Progranulin levelsHPOID:0011018Abnormality of the cell cycleDOID:9255frontotemporal dementiaNANAEFOID:0004625progranulin measurementBrain diseaseAlzheimer's diseaseNAResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov't
194929473rs2123731AGrs2123731210877637.50E-17NANANA533 non-Hispanic white controlsnon-Hispanic white(533)ALL(533)OTHER(533)ALL(533)Progranulin levelsHPOID:0011018Abnormality of the cell cycleDOID:9255frontotemporal dementiaNANAEFOID:0004625progranulin measurementBrain diseaseAlzheimer's diseaseNAResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov't
1910790162rs2569512TCrs2569512210877635.40E-14NANANA533 non-Hispanic white controlsnon-Hispanic white(533)ALL(533)OTHER(533)ALL(533)Progranulin levelsHPOID:0011018Abnormality of the cell cycleDOID:9255frontotemporal dementiaNANAEFOID:0004625progranulin measurementBrain diseaseAlzheimer's diseaseNAResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov't
1941012190rs7258094CTrs7258094210877632.80E-16NANANA533 non-Hispanic white controlsnon-Hispanic white(533)ALL(533)OTHER(533)ALL(533)Progranulin levelsHPOID:0011018Abnormality of the cell cycleDOID:9255frontotemporal dementiaNANAEFOID:0004625progranulin measurementBrain diseaseAlzheimer's diseaseNAResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov't
1946267453rs16980013GTrs16980013210877633.50E-12NANANA533 non-Hispanic white controlsnon-Hispanic white(533)ALL(533)OTHER(533)ALL(533)Progranulin levelsHPOID:0011018Abnormality of the cell cycleDOID:9255frontotemporal dementiaNANAEFOID:0004625progranulin measurementBrain diseaseAlzheimer's diseaseNAResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov't
2023807028rs4407312ACrs4407312210877635.00E-18NANANA533 non-Hispanic white controlsnon-Hispanic white(533)ALL(533)OTHER(533)ALL(533)Progranulin levelsHPOID:0011018Abnormality of the cell cycleDOID:9255frontotemporal dementiaNANAEFOID:0004625progranulin measurementBrain diseaseAlzheimer's diseaseNAResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov't
2025012155rs6138473CTrs6138473210877635.30E-15NANANA533 non-Hispanic white controlsnon-Hispanic white(533)ALL(533)OTHER(533)ALL(533)Progranulin levelsHPOID:0011018Abnormality of the cell cycleDOID:9255frontotemporal dementiaNANAEFOID:0004625progranulin measurementBrain diseaseAlzheimer's diseaseNAResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov't
2060584072rs2296086TGrs2296086210877631.30E-16NANANA533 non-Hispanic white controlsnon-Hispanic white(533)ALL(533)OTHER(533)ALL(533)Progranulin levelsHPOID:0011018Abnormality of the cell cycleDOID:9255frontotemporal dementiaNANAEFOID:0004625progranulin measurementBrain diseaseAlzheimer's diseaseNAResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov't
2061530724rs6011456TGrs6011456210877632.00E-16NANANA533 non-Hispanic white controlsnon-Hispanic white(533)ALL(533)OTHER(533)ALL(533)Progranulin levelsHPOID:0011018Abnormality of the cell cycleDOID:9255frontotemporal dementiaNANAEFOID:0004625progranulin measurementBrain diseaseAlzheimer's diseaseNAResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov't
2143786371rs13051704GCrs13051704210877631.00E-14NANANA533 non-Hispanic white controlsnon-Hispanic white(533)ALL(533)OTHER(533)ALL(533)Progranulin levelsHPOID:0011018Abnormality of the cell cycleDOID:9255frontotemporal dementiaNANAEFOID:0004625progranulin measurementBrain diseaseAlzheimer's diseaseNAResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov't
2219978558rs2073746TCrs2073746210877636.20E-15NANANA533 non-Hispanic white controlsnon-Hispanic white(533)ALL(533)OTHER(533)ALL(533)Progranulin levelsHPOID:0011018Abnormality of the cell cycleDOID:9255frontotemporal dementiaNANAEFOID:0004625progranulin measurementBrain diseaseAlzheimer's diseaseNAResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov't
2221349579rs178293CTrs178293210877631.10E-16NANANA533 non-Hispanic white controlsnon-Hispanic white(533)ALL(533)OTHER(533)ALL(533)Progranulin levelsHPOID:0011018Abnormality of the cell cycleDOID:9255frontotemporal dementiaNANAEFOID:0004625progranulin measurementBrain diseaseAlzheimer's diseaseNAResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov't
2231533225rs5753472GArs5753472210877631.30E-29NANANA533 non-Hispanic white controlsnon-Hispanic white(533)ALL(533)OTHER(533)ALL(533)Progranulin levelsHPOID:0011018Abnormality of the cell cycleDOID:9255frontotemporal dementiaNANAEFOID:0004625progranulin measurementBrain diseaseAlzheimer's diseaseNAResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov't
2250899310rs2236030GArs2236030210877636.90E-16NANANA533 non-Hispanic white controlsnon-Hispanic white(533)ALL(533)OTHER(533)ALL(533)Progranulin levelsHPOID:0011018Abnormality of the cell cycleDOID:9255frontotemporal dementiaNANAEFOID:0004625progranulin measurementBrain diseaseAlzheimer's diseaseNAResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov't
Mapped by lexical matching(Total Items:0)
(Waiting for update.)
Mapped by homologous gene(Total Items:0)
(Waiting for update.)
Disease ID 187
Disease pick disease
Case(Waiting for update.)